<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
March 27, 1997
Date of Report (Date of earliest event reported)
CELL GENESYS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19986 94-3061375
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
342 Lakeside Drive
Foster City, California 94404
(Address of principal executive offices, including zip code)
(415) 358-9600
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
<PAGE>
2
Item 5. Other Events.
On March 27, 1997, Cell Genesys, Inc., a corporation organized under the laws
of the State of Delaware ("Cell Genesys"), announced that, together with its
Abgenix, Inc. ("Abgenix") subsidiary and Abgenix' joint venture partner Japan
Tobacco Inc. ("Japan Tobacco"), it had signed a comprehensive patent cross-
license and settlement agreement with GenPharm International Inc. ("GenPharm")
that resolved all related litigation and claims between the parties (the "Cross-
License and Settlement"). The cross-license agreement includes a worldwide
royalty free cross-license to all issued and related patent applications
pertaining to the generation of fully human monoclonal antibody technologies in
genetically modified strains of mice. Cell Genesys also obtained a license to
certain technology in the field of gene therapy held by GenPharm. As
consideration for the settlement and cross-license agreement, Cell Genesys
agreed to issue a note due September 30, 1998 for $15 million, which bears
interest at seven percent per year and is convertible at the option of GenPharm
into 1,666,666 shares of Cell Genesys common stock at $9.00 per share. The
conversion price is subject to adjustment in 12 months. In addition, Japan
Tobacco agreed to make a cash payment to GenPharm. The agreement also calls for
two potential milestone payments of $7.5 million each to GenPharm based on the
future issuance of certain patents relating to human monoclonal antibody
technology in Europe and Japan and/or the United States. These payments would be
made by Xenotech L.P., which is an equal joint venture of Abgenix and Japan
Tobacco.
In connection with the Cross-License and Settlement, Cell Genesys sought the
consent of Somatix Therapy Corporation, a corporation organized under the laws
of the State of Delaware ("Somatix"), to the Cross-License and Settlement, which
consent was required under the agreement and plan of merger and reorganization,
dated as of January 12, 1997 ("the "Merger Agreement") among Cell Genesys,
Somatix and S Merger Corp., a corporation organized under the laws of the State
of Delaware and a direct wholly owned subsidiary of Cell Genesys, as in effect
prior to its amendment and restatement as of March 27, 1997. Somatix indicated a
willingness to consent to the Cross-License and Settlement, but sought an
amendment to the original Merger Agreement to, among other things, eliminate
certain adjustments to the Common Exchange Ratio and the Series A Exchange Ratio
(each as defined in the Merger Agreement). On March 27, 1997, Somatix consented
to the Cross-License and Settlement and the Merger Agreement was amended and
restated to, among other things, eliminate two contingent downward adjustments
to the Common Exchange Ratio and the Series A Exchange Ratio.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
<TABLE>
<CAPTION>
Exhibit No. Description
----------- -----------
<S> <C>
2.1 Amended and restated agreement and plan of merger and
reorganization, dated as of January 12, 1997, as amended and
restated as of March 27, 1997, among Cell Genesys, Inc., S
Merger Corp. and Somatix Therapy Corporation.
99.1 Press release issued March 27, 1997 announcing the cross-
license and settlement agreement among Cell Genesys, Inc.,
Abgenix, Inc., Japan Tobacco Inc. and GenPharm International
Inc.
</TABLE>
<PAGE>
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CELL GENESYS, INC.
Dated: April 2, 1997 By: /s/ KATHLEEN SEREDA GLAUB
---------------------------
Kathleen Sereda Glaub
Senior Vice President and
Chief Financial Officer
<PAGE>
4
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
2.1 Amended and restated agreement and plan of merger and
reorganization, dated as of January 12, 1997, as amended and
restated as of March 27, 1997, among Cell Genesys, Inc., S
Merger Corp. and Somatix Therapy Corporation.
99.1 Press release issued March 27, 1997 announcing the cross-
license and settlement agreement among Cell Genesys, Inc.,
Abgenix, Inc., Japan Tobacco Inc. and GenPharm International
Inc.
<PAGE>
EXHIBIT 2.1
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
AMENDED AND RESTATED
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
AMONG
CELL GENESYS, INC.
S MERGER CORP.
AND
SOMATIX THERAPY CORPORATION
DATED AS OF JANUARY 12, 1997,
AS AMENDED AND RESTATED AS OF MARCH 27, 1997
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
TABLE OF CONTENTS
<TABLE>
<CAPTION>
PAGE
----
ARTICLE I
DEFINITIONS
<C> <S> <C>
SECTION 1.01. Certain Defined Terms.................................... 1
ARTICLE II
THE MERGER
SECTION 2.01. The Merger............................................... 7
SECTION 2.02. Closing.................................................. 7
SECTION 2.03. Effective Time........................................... 7
SECTION 2.04. Effect of the Merger..................................... 8
SECTION 2.05. Certificate of Incorporation; By-laws; Directors and
Officers of Surviving Corporation........................ 8
ARTICLE III
CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES
SECTION 3.01. Conversion of Securities................................. 8
SECTION 3.02. Exchange of Shares Other than Treasury Shares............ 9
SECTION 3.03. Stock Transfer Books..................................... 9
SECTION 3.04. No Fractional Share Certificates......................... 10
SECTION 3.05. Options and Warrants to Purchase STC Common Stock........ 11
SECTION 3.06. Certain Adjustments...................................... 11
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF STC
SECTION 4.01. Organization and Qualification; Subsidiaries............. 11
SECTION 4.02. Certificate of Incorporation and By-laws................. 12
SECTION 4.03. Capitalization........................................... 12
Authority Relative to This Agreement and the STC Stock
SECTION 4.04. Option Agreement......................................... 12
SECTION 4.05. No Conflict; Required Filings and Consents............... 13
SECTION 4.06. Permits; Compliance with Laws............................ 13
SEC Filings; Financial Statements; Projected Cash
SECTION 4.07. Balances; Operating Budget............................... 14
SECTION 4.08. Absence of Certain Changes or Events..................... 15
SECTION 4.09. Employee Benefit Plans; Labor Matters.................... 15
SECTION 4.10. Tax Matters.............................................. 16
SECTION 4.11. Contracts; Debt Instruments.............................. 16
SECTION 4.12. Litigation............................................... 16
SECTION 4.13. Environmental Matters.................................... 16
SECTION 4.14. Intellectual Property.................................... 17
SECTION 4.15. Taxes.................................................... 17
SECTION 4.16. Opinion of Financial Advisor............................. 17
SECTION 4.17. Brokers.................................................. 17
SECTION 4.18. Certain Interests........................................ 17
</TABLE>
(i)
<PAGE>
TABLE OF CONTENTS--(CONTINUED)
<TABLE>
<CAPTION>
PAGE
----
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF CGI AND MERGER SUB
<C> <S> <C>
SECTION 5.01. Organization and Qualification; Subsidiaries............................ 18
SECTION 5.02. Certificate of Incorporation and By-laws................................ 18
SECTION 5.03. Capitalization.......................................................... 18
SECTION 5.04. Authority Relative to This Agreement and the CGI Stock Option Agreement. 19
SECTION 5.05. No Conflict; Required Filings and Consents.............................. 19
SECTION 5.06. Permits; Compliance with Laws........................................... 20
SECTION 5.07. SEC Filings; Financial Statements....................................... 20
SECTION 5.08. Absence of Certain Changes or Events.................................... 21
SECTION 5.09. Employee Benefit Plans; Labor Matters................................... 21
SECTION 5.10. Tax Matters............................................................. 22
SECTION 5.11. Contracts; Debt Instruments............................................. 22
SECTION 5.12. Litigation.............................................................. 22
SECTION 5.13. Environmental Matters................................................... 23
SECTION 5.14. Intellectual Property................................................... 23
SECTION 5.15. Taxes................................................................... 23
SECTION 5.16. Opinion of Financial Advisor............................................ 23
SECTION 5.17. Brokers................................................................. 23
SECTION 5.18. Certain Interests....................................................... 24
ARTICLE VI
COVENANTS
SECTION 6.01. Conduct of Business by STC Pending the Closing.......................... 24
SECTION 6.02. Conduct of Business by CGI Pending the Closing.......................... 25
SECTION 6.03. Cooperation; Steering Committee......................................... 27
SECTION 6.04. Notices of Certain Events............................................... 27
SECTION 6.05. Access to Information; Confidentiality.................................. 27
SECTION 6.06. No Solicitation of Transactions......................................... 27
SECTION 6.07. Plan of Reorganization.................................................. 28
SECTION 6.08. Subsequent Financial Statements......................................... 28
SECTION 6.09. Control of Operations................................................... 28
SECTION 6.10. Further Action; Consents; Filings....................................... 28
ARTICLE VII
ADDITIONAL AGREEMENTS
SECTION 7.01. Registration Statement; Joint Proxy Statement........................... 29
SECTION 7.02. Stockholders' Meetings.................................................. 30
SECTION 7.03. Affiliates.............................................................. 30
SECTION 7.04. Directors' and Officers' Indemnification and Insurance.................. 31
SECTION 7.05. No Shelf Registration................................................... 32
SECTION 7.06. Public Announcements.................................................... 32
SECTION 7.07. Officers and Directors of CGI........................................... 32
SECTION 7.08. NMS Listing............................................................. 32
SECTION 7.09. Blue Sky................................................................ 32
SECTION 7.10. STC Stock Options....................................................... 32
</TABLE>
(ii)
<PAGE>
TABLE OF CONTENTS--(CONTINUED)
<TABLE>
<CAPTION>
PAGE
----
<C> <S> <C>
SECTION 7.11. [INTENTIONALLY LEFT BLANK]............................... 33
SECTION 7.12. Bridge Facility.......................................... 33
SECTION 7.13. Audited Financial Statements............................. 34
SECTION 7.14. Additional Debt.......................................... 34
ARTICLE VIII
CONDITIONS TO THE MERGER
Conditions to the Obligations of Each Party to Consummate
SECTION 8.01. the Merger............................................... 35
SECTION 8.02. Conditions to the Obligations of STC..................... 35
SECTION 8.03. Conditions to the Obligations of CGI..................... 36
ARTICLE IX
TERMINATION, AMENDMENT AND WAIVER
SECTION 9.01. Termination.............................................. 37
SECTION 9.02. Effect of Termination.................................... 38
SECTION 9.03. Amendment................................................ 38
SECTION 9.04. Waiver................................................... 38
SECTION 9.05. Expenses................................................. 38
ARTICLE X
GENERAL PROVISIONS
SECTION 10.01. Non-Survival of Representations and Warranties........... 39
SECTION 10.02. Notices.................................................. 39
SECTION 10.03. Severability............................................. 39
SECTION 10.04. Assignment; Binding Effect; Benefit...................... 39
SECTION 10.05. Incorporation of Exhibits................................ 40
SECTION 10.06. Specific Performance..................................... 40
SECTION 10.07. Governing Law............................................ 40
SECTION 10.08. Waiver of Jury Trial..................................... 40
SECTION 10.09. Headings................................................. 40
SECTION 10.10. Counterparts............................................. 40
SECTION 10.11. Entire Agreement......................................... 40
</TABLE>
EXHIBITS
Exhibit 1.00(a) Form of STC Stock Option Agreement
Exhibit 1.00(b) Form of CGI Stock Option Agreement
Exhibit 1.00(c) Form of Bridge Facility Promissory Note
Exhibit 1.01(a) Form of Stockholder Resolution Regarding the CGI Amendment
Exhibit 1.01(b) Form of Stockholder Resolution Regarding the STC Amendment
Exhibit 7.03(a) Form of STC Affiliate Agreement
Exhibit 7.03(b) Form of CGI Affiliate Agreement
(iii)
<PAGE>
AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, dated
as of January 12, 1997 (as amended and restated as of March 27, 1997, and as
further amended, supplemented or otherwise modified from time to time, this
"Agreement"), among CELL GENESYS, INC., a corporation organized and existing
under the laws of the State of Delaware ("CGI"), S MERGER CORP., a corporation
organized and existing under the laws of the State of Delaware ("Merger Sub")
and a direct wholly owned subsidiary of CGI, and SOMATIX THERAPY CORPORATION, a
corporation organized and existing under the laws of the State of Delaware
("STC") (references in this Agreement to the "date hereof" or "the date of this
Agreement" or similar terms shall mean and be a reference to January 12, 1997);
WITNESSETH:
WHEREAS, the boards of directors of CGI, Merger Sub and STC have each
determined that it is fair to and in the best interests of their respective
stockholders for Merger Sub to merge (the "Merger") with and into STC upon the
terms and subject to the conditions set forth herein and in accordance with
the General Corporation Law of the State of Delaware (the "General Corporation
Law");
WHEREAS, concurrently with the execution of this Agreement and as an
inducement to CGI and Merger Sub to enter into this Agreement, CGI, Merger Sub
and STC have entered into a stock option agreement, dated as of the date
hereof (the "STC Stock Option Agreement"), substantially in the form attached
hereto as Exhibit 1.00(a) pursuant to which STC has granted to Purchaser an
option to purchase from STC up to 5,441,480 shares of common stock, par value
$.01 per share, of STC (the "STC Common Stock"), representing approximately
19.9 percent of the shares of STC Common Stock issued and outstanding on the
date hereof, at a price of $3.51 per Share, all upon the terms and subject to
the conditions set forth therein;
WHEREAS, concurrently with the execution of this Agreement and as an
inducement to STC to enter into this Agreement, CGI and STC have entered into
a stock option agreement, dated as of the date hereof (the "CGI Stock Option
Agreement"), substantially in the form attached hereto as Exhibit 1.00(b)
pursuant to which CGI has granted to STC an option to purchase from CGI up to
3,286,703 shares of common stock, par value $.001 per share, of CGI (the "CGI
Common Stock"), representing approximately 19.9 percent of the shares of CGI
Common Stock issued and outstanding on the date hereof, at a price of $9.12
per Share, all upon the terms and subject to the conditions set forth therein;
WHEREAS, concurrently with the execution of this Agreement and as an
inducement to CGI and Merger Sub to enter into this Agreement, STC has made a
promissory note in favor of CGI, dated as of the date hereof (the "Bridge
Facility Promissory Note"), substantially in the form attached hereto as
Exhibit 1.00(c) pursuant to which STC has agreed to repay with interest the
aggregate principal amount of all Advances (as defined below) made by CGI
under the Bridge Facility (as defined below), all upon the terms and subject
to the conditions set forth therein; and
WHEREAS, for United States federal income tax purposes, it is intended that
the Merger qualify as a reorganization under the provisions of Section 368 of
the Internal Revenue Code of 1986, as amended (together with the rules and
regulations promulgated thereunder, the "Code");
NOW, THEREFORE, in consideration of the foregoing and the representations,
warranties, covenants and agreements set forth herein, and other good and
valuable consideration, the receipt and adequacy of which are hereby
acknowledged, and intending to be legally bound hereby, the parties hereto
hereby agree as follows:
1
<PAGE>
ARTICLE I
DEFINITIONS
SECTION 1.01. Certain Defined Terms. Unless the context otherwise requires,
the following terms, when used in this Agreement, shall have the respective
meanings specified below:
"Actual Balances" shall mean, on any specified date, the actual balances
of cash, cash equivalents and marketable securities held by STC on such
date.
"affiliate" shall have the meaning specified in Rule 144 promulgated
under the Securities Act.
"Agreement" shall have the meaning specified in the preamble to this
Agreement.
"beneficial owner" shall mean, with respect to any shares of capital
stock, a person who shall be deemed to be the beneficial owner of such
shares (i) which such person or any of its affiliates or associates (as
such term is defined in Rule 12b-2 promulgated under the Exchange Act)
beneficially owns, directly or indirectly, (ii) which such person or any of
its affiliates or associates has, directly or indirectly, (A) the right to
acquire (whether such right is exercisable immediately or subject only to
the passage of time), pursuant to any agreement, arrangement or
understanding or upon the exercise of consideration rights, exchange
rights, warrants or options, or otherwise, or (B) the right to vote
pursuant to any agreement, arrangement or understanding, or (iii) which are
beneficially owned, directly or indirectly, by any other persons with whom
such person or any of its affiliates or associates or person with whom such
person or any of its affiliates or associates has any agreement,
arrangement or understanding for the purpose of acquiring, holding, voting
or disposing of any such shares of capital stock.
"Blue Sky Laws" shall mean state securities or "blue sky" laws.
"Bridge Facility" shall mean the loan facility to be provided by CGI to
STC pursuant to, and upon the terms and subject to the conditions set forth
in, Section 7.12 and the Bridge Facility Promissory Note.
"Bridge Facility Maturity Date" shall mean the earliest to occur of (i)
December 31, 1997; (ii) the 180th day after termination of this Agreement
for any reason whatsoever; and (iii) notwithstanding the immediately
preceding clause (ii), the first business day after termination of this
Agreement by CGI pursuant to Section 9.01(d).
"Bridge Facility Promissory Note" shall have the meaning specified in the
recitals to this Agreement.
"business day" shall mean any day on which the principal offices of the
SEC in Washington, D.C. are open to accept filings, or, in the case of
determining a date when any payment is due, any day on which banks are not
required or authorized by law or executive order to close in San Francisco,
California.
"Certificate of Merger" shall have the meaning specified in Section 2.03.
"CGI" shall have the meaning specified in the preamble to this Agreement.
"CGI Affiliate Agreement" shall have the meaning specified in Section
7.03(b).
"CGI Amendment" shall mean the proposed amendment, substantially in the
form attached hereto as Exhibit 1.01(a), to the certificate of
incorporation of CGI, to be included in the Joint Proxy Statement and voted
on at CGI Stockholders' Meeting.
"CGI Benefit Plans" shall have the meaning specified in Section 5.09(a).
"CGI Common Stock" shall have the meaning specified in the recitals to
this Agreement.
"CGI Director" shall mean any person serving as a director of CGI on the
date hereof who remains a director of CGI after the Effective Time or any
other designee selected by CGI.
"CGI Disclosure Schedule" shall mean the disclosure schedule delivered by
CGI to STC prior to the execution of this Agreement and forming a part
hereof.
2
<PAGE>
"CGI Material Adverse Effect" shall mean any change in or effect on the
business of CGI and the CGI Subsidiaries that is, or could reasonably be
expected to be, materially adverse to the business, assets (including
intangible assets), liabilities (contingent or otherwise), condition
(financial or otherwise) or results of operations of CGI and the CGI
Subsidiaries taken as a whole; provided, however, that any change in or
effect upon the business of CGI and the CGI Subsidiaries that directly or
indirectly arises out of or is attributable to (i) any decrease in the
market price of CGI Common Stock (but not any change or effect underlying
such decrease to the extent such change or effect would otherwise
constitute a CGI Material Adverse Effect) or (ii) circumstances or events
that generally affect the industries in which CGI or the CGI Subsidiaries
operate, shall not constitute a CGI Material Adverse Effect; provided
further that the foregoing proviso shall not be deemed to cause the
condition contained in Section 8.02(a) or (b) not to have been satisfied.
"CGI Material Contract" shall have the meaning specified in Section 5.11.
"CGI Permits" shall have the meaning specified in Section 5.06(a).
"CGI Reports" shall have the meaning specified in Section 5.07(a).
"CGI Right" shall mean the preferred share purchase right to be issued
with respect to each share of CGI Common Stock issued to holders of STC
Capital Stock pursuant to the Merger as provided in Section 3(b) of the CGI
Rights Agreement.
"CGI Rights Agreement" shall mean the preferred shares rights agreement,
dated as of July 28, 1995, between CGI and The First National Bank of
Boston, as rights agent.
"CGI Stock Option Agreement" shall have the meaning specified in the
recitals to this Agreement.
"CGI Stock Plans" shall mean CGI's 1989 Incentive Stock Plan, as amended,
and 1992 Employee Stock Purchase Plan, as amended.
"CGI Stockholders' Meeting" shall have the meaning specified in Section
7.01(a).
"CGI Subsidiaries" shall have the meaning specified in Section 5.01.
"Closing" shall have the meaning specified in Section 2.02.
"Code" shall have the meaning specified in the recitals to this
Agreement.
"Commitment Termination Event" shall mean any of (i) termination of this
Agreement or the Bridge Facility Promissory Note for any reason whatsoever;
(ii) the occurrence of an Event of Default under the Bridge Facility
Promissory Note; and (iii) a material breach of this Agreement or the
Bridge Facility Promissory Note.
"Common Exchange Ratio" shall have the meaning specified in Section
3.01(a).
"Competing Transaction" shall mean any of the following involving CGI or
STC, as the case may be (other than the Merger contemplated by this
Agreement):
(i) any merger, consolidation, share exchange, business combination
or other similar transaction;
(ii) any sale, lease, exchange, mortgage, pledge, transfer or other
disposition of 15 percent or more of the assets of such party and its
subsidiaries, taken as a whole, in a single transaction or series of
transactions;
(iii) any tender offer or exchange offer for 25 percent or more of
the outstanding voting securities of such party or the filing of a
registration statement under the Securities Act in connection
therewith; or
3
<PAGE>
(iv) any person having acquired beneficial ownership or the right to
acquire beneficial ownership of, or any "group" (as such term is
defined under Section 13(d) of the Exchange Act) having been formed
which beneficially owns or has the right to acquire beneficial
ownership of, 25 percent or more of the outstanding voting securities
of such party;
(v) any solicitation by any person (A) proposing any transaction
described in clause (i), (ii), (iii) or (iv) above or (B) who is not a
stockholder of CGI or STC on the date hereof, in opposition to the
approval of this Agreement by the stockholders of CGI or STC; or
(vi) any public announcement of a proposal, plan or intention to do
any of the foregoing or any agreement to engage in any of the
foregoing.
"Confidentiality Agreement" shall mean the confidentiality agreement,
dated as of October 14, 1996, between CGI and STC.
"Costs" shall have the meaning specified in Section 7.04(d).
"DEA" the United States Drug Enforcement Administration.
"DLJ" shall mean Donaldson, Lufkin & Jenrette, financial advisors to STC.
"$" shall mean United States Dollars.
"Effective Time" shall have the meaning specified in Section 2.03.
"Environmental Law" shall mean any Law and any enforceable judicial or
administrative interpretation thereof, including any judicial or
administrative order, consent decree or judgment, relating to pollution or
protection of the environment or natural resources, including, without
limitation, those relating to the use, handling, transportation, treatment,
storage, disposal, release or discharge of Hazardous Material, as in effect
as of the date hereof.
"Environmental Permit" shall mean any permit, approval, identification
number, license or other authorization required under or issued pursuant to
any applicable Environmental Law.
"ERISA" shall mean the Employee Retirement Income Security Act of 1974,
as amended.
"Event of Default" shall have the meaning specified in the Bridge
Facility Promissory Note.
"Excess Shares" shall have the meaning specified in Section 3.04(b).
"Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, together with the rules and regulations promulgated thereunder.
"Exchange Agent" shall have the meaning specified in Section 3.02.
"Exchange Fund" shall have the meaning specified in Section 3.02.
"Expenses" shall mean, with respect to any party hereto, all reasonable
out-of-pocket expenses (including, without limitation, all fees and
expenses of counsel, accountants, investment bankers, experts and
consultants to a party hereto and its affiliates) incurred by such party or
on its behalf in connection with or related to the authorization,
preparation, negotiation, execution and performance of its obligations
pursuant to this Agreement and the consummation of the Merger, the
preparation, printing, filing and mailing of the Registration Statement and
the Joint Proxy Statement, the solicitation of shareholder approvals, the
filing of HSR Act notice, if any, and all other matters related to the
closing of the Merger.
"FDA" shall mean the United States Food and Drug Administration.
"FDCA" shall mean the Federal Food, Drug, and Cosmetic Act, as amended.
"Fletcher" shall mean Fletcher International Limited, a company organized
under the laws of the Cayman Islands.
4
<PAGE>
"Fletcher Put Options" shall mean the put options granted by Fletcher to
STC pursuant to Section 1(a) of the subscription agreement, dated September
24, 1996, between STC and Fletcher and upon the terms and subject to the
conditions set forth in Annex A thereto.
"Fletcher Warrant" shall mean the warrant, dated September 25, 1996,
issued by STC to and in the name of Fletcher.
"General Corporation Law" shall have the meaning specified in the
recitals to this Agreement.
"Governmental Entity" shall mean any United States federal, state or
local or any foreign governmental, regulatory or administrative authority,
agency or commission or any court, tribunal or arbitral body.
"Governmental Order" shall mean any order, writ, judgment, injunction,
decree, stipulation, determination or award entered by or with any
Governmental Entity.
"Hazardous Material" shall mean (i) any petroleum, petroleum products,
by-products or breakdown products, radioactive materials, asbestos-
containing materials or polychlorinated biphenyls or (ii) any chemical,
material or substance defined or regulated as toxic or hazardous or as a
pollutant or contaminant or waste under any applicable Environmental Law.
"HSR Act" shall mean the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended, together with the rules and regulations promulgated
thereunder.
"Indemnified Parties" shall have the meaning specified in Section
7.04(d).
"IRS" shall mean the United States Internal Revenue Service.
"Joint Proxy Statement" shall have the meaning specified in Section
7.01(a).
"Law" shall mean any federal, state or local statute, law, ordinance,
regulation, rule, code, order, other requirement or rule of law of the
United States or any other jurisdiction, including, without limitation, the
FDCA, the Controlled Substances Act, and any other similar act or law.
"Lehman Brothers" shall mean Lehman Brothers, Inc., financial advisors to
CGI.
"Liquidity Notice" shall have the meaning specified in Section 7.12(b).
"Merger" shall have the meaning specified in the recitals to this
Agreement.
"Merger Sub" shall have the meaning specified in the preamble to this
Agreement.
"NASD" shall mean the National Association of Securities Dealers, Inc.
"NMS" shall mean the National Association of Securities Dealers Automated
Quotation System/National Market System.
"Operating Budget" shall have the meaning specified in Section 4.07(e).
"Permitted Financing" shall have the meaning specified in Section
7.14(b).
"person" shall mean an individual, corporation, partnership, limited
partnership, limited liability company, syndicate, person (including,
without limitation, a "person" as defined in Section 13(d)(3) of the
Exchange Act), trust, association, entity or government or political
subdivision, agency or instrumentality of a government.
"Presurrender Dividends" shall have the meaning specified in Section
3.02.
"Projected Cash Balances" shall have the meaning specified in Section
4.07(d).
"Registration Statement" shall have the meaning specified in Section
7.01(a).
"Representatives" shall have the meaning specified in Section 6.05(a).
5
<PAGE>
"SEC" shall have the meaning specified in the recitals to this Agreement.
"Securities Act" shall mean the Securities Act of 1933, as amended,
together with the rules and regulations promulgated thereunder.
"Series A Exchange Ratio" shall have the meaning specified in Section
3.01(b).
"Series A Preferred Stock" shall mean the preferred stock of STC
designated as "Series A-1 Preferred Stock" and "Series A-2 Preferred Stock"
pursuant to the certificate of designation of preferences of preferred
shares of STC filed with the Secretary of State of the State of Delaware on
June 29, 1995.
"Series B Exchange Ratio" shall have the meaning specified in Section
3.01(c).
"Series B Preferred Stock" shall mean the preferred stock of STC
designated as "Series B-1 Preferred Stock" pursuant to the certificate of
designation of preferences of preferred shares of STC filed with the
Secretary of State of the State of Delaware on September 25, 1996.
"STC" shall have the meaning specified in the preamble to this Agreement.
"STC Affiliate Agreement" shall have the meaning specified in Section
7.05(a).
"STC Amendment" shall mean the proposed amendment, substantially in the
form attached hereto as Exhibit 1.01(b), to the certificate of
incorporation of STC, to be included in the Joint Proxy Statement and voted
on at the STC Stockholders' Meeting.
"STC Benefit Plans" shall have the meaning specified in Section 4.09(a).
"STC Capital Stock" shall mean the STC Common Stock, the Series A
Preferred Stock and the Series B Preferred Stock.
"STC Common Stock" shall have the meaning specified in the recitals to
this Agreement.
"STC Director" shall mean any person serving as a director of STC on the
date hereof who becomes a director of CGI at the Effective Time or any
other designee selected by STC.
"STC Disclosure Schedule" shall mean the disclosure schedule delivered by
STC to CGI prior to the execution of this Agreement and forming a part
hereof.
"STC Material Adverse Effect" shall mean any change in or effect on the
business of STC and the STC Subsidiaries that is, or could reasonably be
expected to be, materially adverse to the business, assets (including
intangible assets), liabilities (contingent or otherwise), condition
(financial or otherwise) or results of operations of STC and the STC
Subsidiaries taken as a whole; provided, however, that any change in or
effect upon the business of STC and the STC Subsidiaries that directly or
indirectly arises out of or is attributable to (i) the loss by STC of any
of its corporate partners (including, without limitation, any financial
consequence of such loss of corporate partners) due primarily to the public
announcement of this Agreement and the transactions contemplated hereby,
(ii) any decrease in the market price of the STC Common Stock (but not any
change or effect underlying such decrease to the extent such change or
effect would otherwise constitute an STC Material Adverse Effect), (iii)
circumstances or events that generally affect the industries in which STC
or the STC Subsidiaries operate, (iv) so long as STC has not breached
Section 6.01 in any material respect, any decrease in STC's cash balances
and liquidity from the date hereof and (v) in the event CGI has not,
pursuant to Section 7.12, made available to STC funds which, together with
STC's then existing funds, are sufficient to avoid the triggering of the
rights specified in Section 7(B) of the certificate of designation of STC
applicable to the Series A Preferred Stock, the triggering of such rights,
shall not constitute an STC Material Adverse Effect; provided further that
the foregoing proviso shall not be deemed to cause the condition contained
in Section 8.03(a) or (b) not to have been satisfied.
"STC Material Contract" shall have the meaning specified in Section 4.11.
"STC Permits" shall have the meaning specified in Section 4.06(a).
6
<PAGE>
"STC Reports" shall have the meaning specified in Section 4.07(a).
"STC Stock Option" shall have the meaning specified in Section 3.05.
"STC Stock Option Agreement" shall have the meaning specified in the
recitals to this Agreement.
"STC Stock Plans" shall mean the Hana Biologics, Inc. 1988 Directors
Stock Option Plan, STC's 1988 Stock Option Plan, as amended, the GeneSys
Therapeutic Corporation 1991 Stock Option Plan, STC's 1992 Stock Option
Plan, as amended, and the Merlin Pharmaceutical Corporation 1993 Stock
Option Plan.
"STC Stockholders' Meeting" shall have the meaning specified in Section
7.01(a).
"STC Subsidiaries" shall have the meaning specified in Section 4.01.
"subsidiary" shall mean, with respect to any person, any corporation,
limited liability company, partnership, joint venture or other legal entity
of which such person (either alone or through or together with any other
subsidiary of such person) owns, directly or indirectly, a majority of the
stock or other equity interests, the holders of which are generally
entitled to vote for the election of the board of directors or other
governing body of such corporation or other legal entity.
"Surviving Corporation" shall have the meaning specified in Section 2.01.
"Taxes" shall mean any and all taxes, fees, levies, duties, tariffs,
imposts and other charges of any kind (together with any and all interest,
penalties, additions to tax and additional amounts imposed with respect
thereto) imposed by any Governmental Entity or taxing authority, including,
without limitation, taxes or other charges on or with respect to income,
franchises, windfall or other profits, gross receipts, property, sales,
use, capital stock, payroll, employment, social security, workers'
compensation, unemployment compensation or net worth; taxes or other
charges in the nature of excise, withholding, ad valorem, stamp, transfer,
value-added or gains taxes; license, registration and documentation fees;
and customers' duties, tariffs and similar charges.
"Terminating CGI Breach" shall have the meaning specified in Section
9.01(h).
"Terminating STC Breach" shall have the meaning specified in Section
9.01(g).
"Trust" shall have the meaning specified in Section 3.04(c).
"U.S. GAAP" shall mean United States generally accepted accounting
principles.
ARTICLE II
THE MERGER
SECTION 2.01. The Merger. Upon the terms and subject to the conditions set
forth in this Agreement, and in accordance with the General Corporation Law,
at the Effective Time, Merger Sub shall be merged with and into STC. As a
result of the Merger, the separate corporate existence of Merger Sub shall
cease and STC shall continue as the surviving corporation of the Merger (the
"Surviving Corporation").
SECTION 2.02. Closing. Unless this Agreement shall have been terminated and
the Merger shall have been abandoned pursuant to Section 9.01 and subject to
the satisfaction or waiver of the conditions set forth in Article VIII, the
consummation of the Merger shall take place as promptly as practicable (and in
any event within three business days) after satisfaction or waiver of the
conditions set forth in Article VIII, at a closing (the "Closing") to be held
at the offices of Shearman & Sterling, 555 California Street, San Francisco,
California, unless another date, time or place is agreed to by STC and CGI.
SECTION 2.03. Effective Time. At the time of the Closing, the parties shall
cause the Merger to be consummated by filing a certificate of merger (the
"Certificate of Merger") with the Secretary of State of the State of Delaware
in such form as required by, and executed in accordance with the relevant
provisions of, the General Corporation Law (the date and time of such filing
being the "Effective Time").
7
<PAGE>
SECTION 2.04. Effect of the Merger. At the Effective Time, the effect of the
Merger shall be as provided in the applicable provisions of the General
Corporation Law. Without limiting the generality of the foregoing, and subject
thereto, at the Effective Time, except as otherwise provided herein, all the
property, rights, privileges, powers and franchises of STC and Merger Sub
shall vest in the Surviving Corporation, and all debts, liabilities and duties
of STC and Merger Sub shall become the debts, liabilities and duties of the
Surviving Corporation.
SECTION 2.05. Certificate of Incorporation; By-laws; Directors and Officers
of Surviving Corporation. Unless otherwise agreed by STC and CGI prior to the
Effective Time, at the Effective Time:
(a) the certificate of incorporation and by-laws of Merger Sub, as in
effect immediately prior to the Effective Time, shall be the certificate of
incorporation and by-laws of the Surviving Corporation until thereafter
amended as provided by Law and such certificate of incorporation or by-
laws;
(b) the officers of Merger Sub immediately prior to the Effective Time
shall be the initial officers of the Surviving Corporation until their
successors are elected or appointed and qualified or until their
resignation or removal; and
(c) the directors of Merger Sub immediately prior to the Effective Time
shall be the initial directors of the Surviving Corporation until their
successors are elected or appointed and qualified or until their
resignation or removal.
ARTICLE III
CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES
SECTION 3.01. Conversion of Securities. At the Effective Time, by virtue of
the Merger and without any action on the part of Merger Sub, STC or the
holders of any of the following securities:
(a) Each share of STC Common Stock issued and outstanding immediately
prior to the Effective Time (other than any shares of STC Common Stock to
be cancelled pursuant to Section 3.01(d)) and all rights in respect thereof
shall forthwith cease to exist and shall be converted into and become
exchangeable for the number of shares of CGI Common Stock (and associated
CGI Rights) equal to .3850 (the "Common Exchange Ratio");
(b) Each share of Series A Preferred Stock issued and outstanding
immediately prior to the Effective Time (other than any shares of Series A
Preferred Stock to be cancelled pursuant to Section 3.01(d)) and all rights
in respect thereof shall forthwith cease to exist and shall be converted
into and become exchangeable for the number of shares of CGI Common Stock
(and associated CGI Rights) equal to the product of 6.25 multiplied by the
Common Exchange Ratio (the "Series A Exchange Ratio");
(c) Each share of Series B Preferred Stock issued and outstanding
immediately prior to the Effective Time (other than any shares of Series B
Preferred Stock to be cancelled pursuant to Section 3.01(d)) and all rights
in respect thereof shall forthwith cease to exist and shall be converted
into and become exchangeable for the number of shares of CGI Common Stock
(and associated CGI Rights) equal to the quotient of $150.00 divided by the
average of the daily closing prices of the CGI Common Stock over the 30-day
period ending three days prior to the Effective Time (the "Series B
Exchange Ratio");
(d) Each share of STC Capital Stock held in the treasury of STC and each
share of STC Capital Stock owned by CGI or any direct or indirect wholly
owned subsidiary of CGI or of STC immediately prior to the Effective Time
shall be cancelled and extinguished without any conversion thereof and no
payment shall be made with respect thereto; and
(e) Each share of common stock, par value $.01 per share, of Merger Sub
issued and outstanding immediately prior to the Effective Time and all
rights in respect thereof shall forthwith cease to exist and shall be
converted into and become exchangeable for one newly and validly issued,
fully paid and nonassessable share of common stock of the Surviving
Corporation.
8
<PAGE>
SECTION 3.02. Exchange of Shares Other than Treasury Shares. Subject to the
terms and conditions hereof, at or prior to the Effective Time, CGI shall
appoint, and shall retain for a period of at least six months after the
Effective Time, an exchange agent to effect the exchange of shares of STC
Capital Stock for CGI Common Stock (and associated CGI Rights) in accordance
with the provisions of this Article III (the "Exchange Agent"). As soon as
reasonably practicable after the Effective Time, CGI will instruct the
Exchange Agent to mail to each holder of record of STC Capital Stock (i) a
letter of transmittal (which shall specify that delivery shall be effected,
and risk of loss and title to certificates evidencing shares of STC Capital
Stock shall pass, only upon proper delivery of such certificates to the
Exchange Agent and shall be in such form and have such other provisions as CGI
may reasonably specify) and (ii) instructions to effect the surrender of
certificates evidencing shares of STC Capital Stock in exchange for
certificates evidencing shares of CGI Common Stock (and associated CGI Rights)
and, in lieu of any fractional shares thereof, cash. From time to time after
the Effective Time, CGI shall deposit, or cause to be deposited, certificates
representing CGI Common Stock (and associated CGI Rights) for conversion of
shares of STC Capital Stock in accordance with the provisions of Section 3.01
(such certificates, together with any dividends or distributions with respect
thereto, being herein referred to as the "Exchange Fund"). Commencing
immediately after the Effective Time and until the appointment of the Exchange
Agent shall be terminated, each holder of a certificate or certificates
theretofore evidencing shares of STC Capital Stock may surrender the same,
together with a duly executed letter of transmittal and such other customary
documents as CGI may reasonably require, to the Exchange Agent, and, after the
appointment of the Exchange Agent shall be terminated, any such holder may
surrender any such certificate, letter of transmittal and other documents to
CGI. Such holder shall be entitled upon such surrender to receive in exchange
therefor a certificate or certificates representing the number of full shares
of CGI Common Stock (and associated CGI Rights) into which the shares of STC
Capital Stock theretofore represented by the certificate or certificates so
surrendered shall have been converted in accordance with the provisions of
Section 3.01, together with a cash payment in lieu of fractional shares, if
any, in accordance with Section 3.04, and all such shares of CGI Common Stock
(and associated CGI Rights) shall be deemed to have been issued at the
Effective Time. Until so surrendered and exchanged, each outstanding
certificate which, prior to the Effective Time, represented issued and
outstanding shares of STC Capital Stock shall be deemed for all corporate
purposes of CGI, other than the payment of dividends and other distributions,
if any, to evidence ownership of the number of full shares of CGI Common Stock
(and associated CGI Rights) into which the shares of STC Capital Stock
theretofore represented thereby shall have been converted at the Effective
Time. Unless and until any such certificate theretofore representing shares of
STC Capital Stock is so surrendered, no dividend or other distribution, if
any, payable to the holders of record of CGI Common Stock as of any date
subsequent to the Effective Time shall be paid to the holder of such
certificate in respect thereof. Upon the surrender of any such certificate
theretofore representing shares of STC Capital Stock, however, the record
holder of the certificate or certificates representing shares of CGI Common
Stock issued in exchange therefor shall receive from the Exchange Agent or
from CGI, as the case may be, payment of the amount of dividends and other
distributions, if any, which as of any date subsequent to the Effective Time
and until such surrender shall have become payable with respect to such number
of shares of CGI Common Stock ("Presurrender Dividends"). No interest shall be
payable with respect to the payment of Presurrender Dividends upon the
surrender of certificates theretofore representing shares of STC Capital
Stock. After the appointment of the Exchange Agent shall have been terminated,
such holders of CGI Common Stock which have not received payment of
Presurrender Dividends shall look only to CGI for payment thereof.
Notwithstanding the foregoing provisions of this Section 3.02, risk of loss
and title to such certificates representing shares of STC Capital Stock shall
pass only upon proper delivery of such certificates to the Exchange Agent, and
neither the Exchange Agent nor any party hereto shall be liable to a holder of
shares of STC Capital Stock for any CGI Common Stock or dividends or
distributions thereon delivered to a public official pursuant to any
applicable abandoned property, escheat or similar law or to a transferee
pursuant to Section 3.03.
SECTION 3.03. Stock Transfer Books. At the Effective Time, the stock
transfer books of STC with respect to shares of STC Capital Stock shall each
be closed, and there shall be no further registration of transfers of shares
of STC Capital Stock thereafter on the records of any such stock transfer
books. In the event of a transfer of ownership of shares of STC Capital Stock
that is not registered in the stock transfer records of STC, at the Effective
Time, a certificate or certificates representing the number of full shares of
CGI Common Stock into
9
<PAGE>
which such shares of STC Capital Stock shall have been converted shall be
issued to the transferee together with a cash payment in lieu of fractional
shares, if any, in accordance with Section 3.04, and a cash payment in the
amount of Presurrender Dividends, if any, in accordance with Section 3.02, if
the certificate or certificates representing such shares of STC Capital Stock
is or are surrendered as provided in Section 3.02, accompanied by all
documents required to evidence and effect such transfer and by evidence of
payment of any applicable stock transfer tax.
SECTION 3.04. No Fractional Share Certificates. (a) No scrip or fractional
share certificate for CGI Common Stock shall be issued upon the surrender for
exchange of certificates evidencing shares of STC Capital Stock, and an
outstanding fractional share interest shall not entitle the owner thereof (i)
to vote, (ii) to receive dividends or (iii) to any rights of a stockholder of
CGI or of the Surviving Corporation with respect to such fractional share
interest.
(b) As promptly as practicable following the Effective Time, the Exchange
Agent shall determine the excess of (i) the number of full shares of CGI
Common Stock to be issued and delivered to the Exchange Agent pursuant to
Section 3.02 over (ii) the aggregate number of full shares of CGI Common Stock
to be distributed to holders of STC Capital Stock pursuant to Section 3.02
(such excess being herein called the "Excess Shares"). Following the Effective
Time, the Exchange Agent, as agent for the holders of STC Capital Stock, shall
sell the Excess Shares at then prevailing prices on the NMS, all in the manner
provided in subsection (c) of this Section 3.04.
(c) The sale of the Excess Shares by the Exchange Agent shall be executed on
the NMS through one or more member firms of such exchange and shall be
executed in round lots to the extent practicable. The Exchange Agent shall use
all reasonable efforts to complete the sale of the Excess Shares as promptly
following the Effective Time as, in the Exchange Agent's reasonable judgment,
is practicable consistent with obtaining the best execution of such sales in
light of prevailing market conditions. Until the net proceeds of such sale or
sales have been distributed to the holders of STC Capital Stock, the Exchange
Agent shall hold such proceeds in trust for the holders of STC Capital Stock
(the "Trust"). CGI shall pay all commissions, transfer taxes and other out-of-
pocket transaction costs, including the expenses and compensation of the
Exchange Agent, incurred in connection with such sale of Excess Shares. The
Exchange Agent shall determine the portion of the Trust to which each holder
of STC Capital Stock shall be entitled, if any, by multiplying the amount of
the aggregate net proceeds comprising the Trust by a fraction the numerator of
which is the amount of fractional share interests to which such holder of STC
Capital Stock is entitled (after taking into account all shares of STC Capital
Stock held at the Effective Time by such holder) and the denominator of which
is the aggregate amount of fractional share interests to which all holders of
STC Capital Stock are entitled.
(d) Notwithstanding the provisions of subsections (b) and (c) of this
Section 3.04, CGI may, in lieu of the issuance and sale of Excess Shares and
the making of the payments contemplated in such subsections, pay to the
Exchange Agent an amount in cash sufficient for the Exchange Agent to pay each
holder of STC Capital Stock an amount in cash equal to the product obtained by
multiplying (i) the fractional share interest to which such holder would
otherwise be entitled (after taking into account all shares of STC Capital
Stock held at the Effective Time by such holder) by (ii) the closing price for
a share of CGI Common Stock on the NMS on the first business day immediately
following the Effective Time, and, in such case, all references herein to the
cash proceeds of the sale of the Excess Shares and similar references shall be
deemed to mean and refer to the payments calculated as set forth in this
subsection (d). In such event, Excess Shares shall not be issued or otherwise
transferred to the Exchange Agent pursuant to Section 3.02.
(e) As soon as practicable after the determination of the amount of cash, if
any, to be paid to holders of STC Capital Stock with respect to any fractional
share interests, the Exchange Agent shall make available such amounts, net of
any required withholding, excise or similar tax, to such holders of STC
Capital Stock, subject to and in accordance with the terms of Section 3.02.
(f) Any portion of the Exchange Fund or the Trust which remains
undistributed for six months after the Effective Time shall be delivered to
CGI, and any holder of STC Capital Stock who has not theretofore complied
10
<PAGE>
with the provisions of this Article III shall thereafter look only to CGI for
satisfaction of their claims for CGI Common Stock or any cash in lieu of
fractional shares of CGI Common Stock and any Presurrender Dividends.
SECTION 3.05. Options and Warrants to Purchase STC Common Stock. At the
Effective Time, each option or warrant granted by STC to purchase shares of
STC Common Stock (each, an "STC Stock Option") which is outstanding and
unexercised immediately prior to the Effective Time, shall be assumed by CGI
and converted into an option or warrant to purchase shares of CGI Common Stock
in such number and at such exercise price as provided below and otherwise
having the same terms and conditions as in effect immediately prior to the
Effective Time (except to the extent that such terms, conditions and
restrictions may be altered in accordance with their terms as a result of the
Merger):
(a) the number of shares of CGI Common Stock to be subject to the new
option or warrant shall be equal to the product of (i) the number of shares
of STC Common Stock subject to the original option or warrant and (ii) the
Common Exchange Ratio;
(b) the exercise price per share of CGI Common Stock under the new option
or warrant shall be equal to the quotient of (i) the exercise price per
share of STC Common Stock under the original option or warrant divided by
(ii) the Common Exchange Ratio; and
(c) upon each exercise of options or warrants by a holder thereof, the
aggregate number of shares of CGI Common Stock deliverable upon such
exercise shall be rounded down, if necessary, to the nearest whole share
and the aggregate exercise price shall be rounded up, if necessary, to the
nearest cent.
The adjustments provided herein with respect to any options which are
"incentive stock options" (as defined in Section 422 of the Code) shall be
effected in a manner consistent with the requirements of Section 424(a) of the
Code.
SECTION 3.06. Certain Adjustments. If between the date of this Agreement and
the Effective Time, the outstanding shares of STC Capital Stock or CGI Common
Stock shall be changed into a different number of shares by reason of any
reclassification, recapitalization, split-up, combination or exchange of
shares, or any dividend payable in stock or other securities shall be declared
thereon with a record date within such period, the exchange ratios established
pursuant to the provisions of Section 3.01 shall be adjusted accordingly to
provide to the holders of STC Capital Stock the same economic effect as
contemplated by this Agreement prior to such reclassification,
recapitalization, split-up, combination, exchange or dividend.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF STC
STC hereby represents and warrants to CGI and Merger Sub that:
SECTION 4.01. Organization and Qualification; Subsidiaries. Each of STC and
each subsidiary of STC (the "STC Subsidiaries") has been duly organized and is
validly existing and in good standing (to the extent applicable) under the
laws of the jurisdiction of its incorporation or organization, as the case may
be, and has the requisite corporate power and authority and all necessary
governmental approvals to own, lease and operate its properties and to carry
on its business as it is now being conducted, except where the failure to be
so organized, existing or in good standing or to have such power, authority
and governmental approvals could not reasonably be expected to have,
individually or in the aggregate, an STC Material Adverse Effect. Each of STC
and each STC Subsidiary is duly qualified or licensed to do business, and is
in good standing (to the extent applicable), in each jurisdiction where the
character of the properties owned, leased or operated by it or the nature of
its business makes such qualification or licensing necessary, except for such
failures to be so qualified or licensed and in good standing that could not
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect.
11
<PAGE>
SECTION 4.02. Certificate of Incorporation and By-laws. The copies of STC's
certificate of incorporation and by-laws that are incorporated by reference as
exhibits to STC's Form 10-K for the period ending June 30, 1996 (the "STC 1996
10-K") are true, complete and correct copies thereof. Such certificate of
incorporation and by-laws are in full force and effect. STC is not in
violation of any of the provisions of its certificate of incorporation or by-
laws.
SECTION 4.03. Capitalization. The authorized capital stock of STC consists
of 40,000,000 shares of STC Common Stock and 1,000,000 shares of preferred
stock. As of January 6, 1997, (i) 27,344,121 shares of STC Common Stock are
issued and outstanding, all of which are validly issued, fully paid and
nonassessable, (ii) no shares of STC Common Stock are held in the treasury of
STC, (iii) no shares of STC Common Stock are held by the STC Subsidiaries,
(iv) 3,052,491 shares of STC Common Stock are reserved for future issuance
pursuant to employee stock options or stock incentive rights granted under the
STC Stock Plans, (v) 5,441,480 shares of STC Common Stock are reserved for
issuance pursuant to the STC Stock Option Agreement, (vi) 2,047,651 shares of
STC Common Stock are reserved for issuance upon conversion of the Series A
Preferred Stock, (vii) 1,500,000 shares of STC Common Stock are reserved for
issuance upon conversion of the Series B Preferred Stock, (viii) 224,000
shares of Series A-1 Preferred Stock are issued and outstanding, (ix) 23,651
shares of Series A-2 Preferred Stock are issued and outstanding and (x) 33,333
shares of Series B Preferred Stock are issued and outstanding. There has been
no change in the capitalization of STC since January 6, 1997, excluding the
exercise of outstanding stock options. Except for the STC Stock Option
Agreement and shares of STC Common Stock issuable pursuant to the STC Stock
Plans or pursuant to agreements or arrangements described in Section 4.03 of
the STC Disclosure Schedule, and the warrants to purchase 889,000 shares of
STC Common Stock issued to holders of the Series A-1 Preferred Stock, there
are no options, warrants or other rights, agreements, arrangements or
commitments of any character to which STC is a party or by which STC is bound
relating to the issued or unissued capital stock of STC or any STC Subsidiary
or obligating STC or any STC Subsidiary to issue or sell any shares of capital
stock of, or other equity interests in, STC or any STC Subsidiary. All shares
of STC Common Stock subject to issuance as aforesaid, upon issuance prior to
the Effective Time on the terms and conditions specified in the instruments
pursuant to which they are issuable, will be duly authorized, validly issued,
fully paid and nonassessable. Except for the Fletcher Warrant, there are no
outstanding contractual obligations of STC or any STC Subsidiary to
repurchase, redeem or otherwise acquire any shares of STC Capital Stock or any
capital stock of any STC Subsidiary. Each outstanding share of capital stock
of each STC Subsidiary is duly authorized, validly issued, fully paid and
nonassessable and each such share owned by STC or another STC Subsidiary is
free and clear of all security interests, liens, claims, pledges, options,
rights of first refusal, agreements, limitations on STC's or such other STC
Subsidiary's voting rights, charges and other encumbrances of any nature
whatsoever, except where the failure to own such shares free and clear could
not reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect. Except as set forth in Section 4.03 of the STC
Disclosure Schedule, there are no material outstanding contractual obligations
of STC or any STC Subsidiary to provide funds to, or make any material
investment (in the form of a loan, capital contribution or otherwise) in, any
STC Subsidiary or any other person.
SECTION 4.04. Authority Relative to This Agreement and the STC Stock Option
Agreement. STC has all necessary corporate power and authority to execute and
deliver this Agreement and the STC Stock Option Agreement, to perform its
obligations hereunder and thereunder and to consummate the transactions
contemplated hereby and thereby. The execution and delivery of this Agreement
and the STC Stock Option Agreement by STC and the consummation by STC of the
transactions contemplated hereby and thereby have been duly and validly
authorized by all necessary corporate action, and no other corporate
proceedings on the part of STC are necessary to authorize this Agreement or
the STC Stock Option Agreement or to consummate such transactions (other than
the approval of this Agreement and the Merger by the holders of a majority of
the outstanding shares of STC Capital Stock and Series A Preferred Stock
entitled to vote with respect thereto at the STC Stockholders' Meeting, in
each case voting together as a single class, and the filing and recordation of
the Certificate of Merger as required by the General Corporation Law). This
Agreement and the STC Stock Option Agreement have been duly executed and
delivered by STC and, assuming the due authorization, execution and delivery
by the other parties hereto and thereto, constitute legal, valid and binding
obligations of STC, enforceable against STC in accordance with their terms.
12
<PAGE>
SECTION 4.05. No Conflict; Required Filings and Consents. (a) The execution
and delivery of this Agreement and the STC Stock Option Agreement by STC do
not, and the performance by STC of its obligations hereunder and thereunder
and the consummation of the Merger will not, (i) conflict with or violate any
provision of the certificate of incorporation or by-laws of STC or any
equivalent organizational documents of any STC Subsidiary, (ii) assuming that
all consents, approvals, authorizations and permits described in Section
4.05(b) have been obtained and all filings and notifications described in
Section 4.05(b) have been made, conflict with or violate any Law applicable to
STC or any STC Subsidiary or by which any property or asset of STC or any STC
Subsidiary is bound or affected or (iii) except as set forth in Section
4.05(a) of the STC Disclosure Schedule, result in any breach of or constitute
a default (or an event which with the giving of notice or lapse of time or
both could reasonably be expected to become a default) under, or give to
others any right of termination, amendment, acceleration or cancellation of,
or result in the creation of a lien or other encumbrance on any property or
asset of STC or any STC Subsidiary pursuant to, any note, bond, mortgage,
indenture, contract, agreement, lease, license, permit, franchise or other
instrument or obligation, except, with respect to clauses (ii) and (iii), for
any such conflicts, violations, breaches, defaults or other occurrences which
could not reasonably be expected, individually or in the aggregate, (A) to
have an STC Material Adverse Effect or (B) to prevent or materially delay the
performance by STC of its obligations pursuant to this Agreement or the STC
Stock Option Agreement or the consummation of the Merger.
(b) The execution and delivery of this Agreement and the STC Stock Option
Agreement by STC do not, and the performance by STC of its obligations
hereunder and thereunder and the consummation of the Merger will not, require
any consent, approval, authorization or permit of, or filing by STC with or
notification by STC to, any Governmental Entity except (i) pursuant to
applicable requirements of the Exchange Act, the Securities Act, Blue Sky
Laws, the rules and regulations of the NASD, state takeover laws, the
premerger notification requirements of the HSR Act, if any, and the filing and
recordation of the Certificate of Merger as required by the General
Corporation Law, and (ii) where failure to obtain such consents, approvals,
authorizations or permits, or to make such filings or notifications, could not
reasonably be expected, individually or in the aggregate, (A) to have an STC
Material Adverse Effect or (B) to prevent or materially delay the performance
by STC of its obligations pursuant to this Agreement or the STC Stock Option
Agreement or the consummation of the Merger.
SECTION 4.06. Permits; Compliance with Laws. (a) STC and the STC
Subsidiaries are in possession of all franchises, grants, authorizations,
licenses, establishment registrations, product listings, permits, easements,
variances, exceptions, consents, certificates, approvals and orders of any
Governmental Entity, including, without limitation, the FDA, the DEA, and
similar authorities in other jurisdictions, necessary for STC or any STC
Subsidiary to own, lease and operate its properties or to produce, store,
distribute and market its products or otherwise to carry on its business as it
is now being conducted (the "STC Permits"), except where the failure to have,
or the suspension or cancellation of, any of the STC Permits could not
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect, and, as of the date of this Agreement, no suspension
or cancellation of any of the STC Permits is pending or, to the knowledge of
STC, threatened, except where the failure to have, or the suspension or
cancellation of, any of the STC Permits could not reasonably be expected to
have, individually or in the aggregate, an STC Material Adverse Effect.
Neither STC nor any STC Subsidiary is in conflict with, or in default or
violation of, (i) any Law applicable to STC or any STC Subsidiary or by which
any property or asset of STC or any STC Subsidiary is bound or affected or
(ii) any STC Permits, except in the case of clauses (i) and (ii) for any such
conflicts, defaults or violations that could not reasonably be expected to
have, individually or in the aggregate, an STC Material Adverse Effect.
(b) Except as disclosed in the STC Reports or in Section 4.06(b) of the STC
Disclosure Schedule or as could not reasonably be expected to have,
individually or in the aggregate, an STC Material Adverse Effect:
(i) to the knowledge of STC, all of the clinical studies which have been,
or are being, conducted by or for STC and the STC Subsidiaries are being
conducted in substantial compliance with generally accepted good clinical
practices and all applicable government regulatory requirements; and
(ii) to the knowledge of STC, none of STC, the STC Subsidiaries or any of
their respective officers, employees or agents (during the term of such
person's employment by STC or any STC Subsidiary or while
13
<PAGE>
acting as an agent of STC or any STC Subsidiary, or, to STC's knowledge,
prior to such employment) has made any untrue statement of a material fact
or fraudulent statement to the FDA or any similar Governmental Entity,
failed to disclose a material fact required to be disclosed to the FDA or
similar Governmental Entity, or committed an act, made a statement or
failed to make a statement that could reasonably be expected to provide a
basis for the FDA or similar Governmental Entity to invoke its policy
respecting "Fraud, Untrue Statements of Material Facts, Bribery, and
Illegal Gratuities" or similar governmental policy or Law.
SECTION 4.07. SEC Filings; Financial Statements; Projected Cash Balances;
Operating Budget. (a) Except as disclosed in Section 4.07 of the STC
Disclosure Schedule, STC has timely filed all forms, reports and documents
required to be filed by it with the SEC and the NASD since June 30, 1994
through the date of this Agreement (collectively and as amended, the "STC
Reports"). Each STC Report (i) was prepared in accordance with the
requirements of the Securities Act, the Exchange Act or the rules and
regulations of the NASD, as the case may be, and (ii) did not at the time it
was filed contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to make the
statements made therein, in the light of the circumstances under which they
were made, not misleading. No STC Subsidiary is subject to the periodic
reporting requirements of the Exchange Act or required to file any form,
report or other document with the SEC, the NASD, any other stock exchange or
any other comparable Governmental Entity.
(b) Each of the consolidated financial statements (including, in each case,
any notes thereto) contained in the STC Reports was prepared, and each of the
consolidated financial statements (including, in each case, the notes thereto)
prepared and delivered pursuant to Section 7.13, if any, will be prepared, in
accordance with U.S. GAAP applied on a consistent basis throughout the periods
indicated (except as may be indicated in the notes thereto) and each presented
or will present fairly, in all material respects, the consolidated financial
position of STC and the consolidated STC Subsidiaries as at the respective
dates thereof and for the respective periods indicated therein, except as
otherwise noted therein (subject, in the case of unaudited statements, to
normal and recurring year-end adjustments which did not have and could not
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect).
(c) Except as and to the extent set forth or reserved against on the
consolidated balance sheet of STC and the STC Subsidiaries as reported in the
STC Reports, including the notes thereto, none of STC or any STC Subsidiary
has any liabilities or obligations of any nature (whether accrued, absolute,
contingent or otherwise) that would be required to be reflected on a balance
sheet or in notes thereto prepared in accordance with U.S. GAAP, except for
liabilities or obligations incurred in the ordinary course of business
consistent with past practice since June 30, 1996 that have not had and could
not reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect.
(d) Within five days after the date hereof, STC shall furnish CGI with a
detailed schedule of STC's projected balances (the "Projected Cash Balances")
of cash, cash equivalents and marketable securities of STC for each month
during the period from the date hereof through August 31, 1997. The Projected
Cash Balances will be prepared (and any revised Projected Cash Balances
delivered after the date hereof will be prepared) by senior management of STC
on the basis of assumptions and supplemental data which represent a reasonable
basis for such preparation, and will reflect (and any revised Projected Cash
Balances delivered after the date hereof will reflect) the best currently
available estimates and judgment of senior management of STC as to the
expected future balances of cash, cash equivalents and marketable securities
of the STC for the periods included.
(e) Within five days after the date hereof, STC shall furnish CGI with a
detailed schedule of STC's projected operating budget (the "Operating Budget")
of STC for each month during the period from the date hereof through August
31, 1997. The Operating Budget will be prepared (and any revised Operating
Budget delivered after the date hereof will be prepared) by senior management
of STC on the basis of assumptions and supplemental data which represent a
reasonable basis for such preparation, and will reflect (and any revised
Operating Budget delivered after the date hereof will reflect) the best
currently available estimates and judgment of senior management of STC as to
the future operating expenses of STC expected to be incurred by STC in the
ordinary course consistent with past practice for the periods included.
14
<PAGE>
SECTION 4.08. Absence of Certain Changes or Events. Since June 30, 1996,
except as contemplated by or as disclosed in this Agreement, as set forth in
Section 4.08 of the STC Disclosure Schedule or as disclosed in any STC Report
filed since June 30, 1996, STC and the STC Subsidiaries have conducted their
businesses only in the ordinary course consistent with past practice and,
since such date, there has not been (i) any STC Material Adverse Effect
excluding any changes and effects resulting from changes in economic,
regulatory or political conditions or changes in conditions generally
applicable to the industries in which STC and the STC Subsidiaries are
involved, (ii) any event that could reasonably be expected to prevent or
materially delay the performance of its obligations pursuant to this Agreement
and the consummation of the Merger by STC, (iii) any material change by STC in
its accounting methods, principles or practices, (iv) any declaration, setting
aside or payment of any dividend or distribution in respect of the shares of
STC Capital Stock or any redemption, purchase or other acquisition of any of
STC's securities or (v) any increase in the compensation or benefits or
establishment of any bonus, insurance, severance, deferred compensation,
pension, retirement, profit sharing, stock option (including, without
limitation, the granting of stock options, stock appreciation rights,
performance awards or restricted stock awards), stock purchase or other
employee benefit plan, or any other increase in the compensation payable or to
become payable to any executive officers of STC or any STC Subsidiary except
in the ordinary course of business consistent with past practice.
SECTION 4.09. Employee Benefit Plans; Labor Matters. (a) With respect to
each employee benefit plan, program, arrangement and contract (including,
without limitation, any "employee benefit plan", as defined in Section 3(3) of
ERISA) maintained or contributed to by STC or any STC Subsidiary, or with
respect to which STC or any STC Subsidiary could incur liability under Section
4069, 4212(c) or 4204 of ERISA (the "STC Benefit Plans"), STC has delivered or
made available to CGI a true, complete and correct copy of (i) such STC
Benefit Plan and the most recent summary plan description related to such STC
Benefit Plan, if a summary plan description is required therefor, (ii) each
trust agreement or other funding arrangement relating to such STC Benefit
Plan, (iii) the most recent annual report (Form 5500) filed with the IRS) with
respect to such STC Benefit Plan, (iv) the most recent actuarial report or
financial statement relating to such STC Benefit Plan and (v) the most recent
determination letter issued by the IRS with respect to such STC Benefit Plan,
if it is qualified under Section 401(a) of the Code.
(b) Each STC Benefit Plan has been administered in all material respects in
accordance with its terms and all contributions required to be made under the
terms of any of the STC Benefit Plans as of the date of this Agreement have
been timely made or have been reflected on the most recent consolidated
balance sheet filed or incorporated by reference in the STC Reports prior to
the date of this Agreement. Except as set forth in Section 4.09(b) of the STC
Disclosure Schedule, with respect to the STC Benefit Plans, no event has
occurred and, to the knowledge of STC, there exists no condition or set of
circumstances in connection with which STC or any STC Subsidiary could be
subject to any liability under the terms of such STC Benefit Plans, ERISA, the
Code or any other applicable Law which could reasonably be expected to have,
individually or in the aggregate, an STC Material Adverse Effect.
(c) Except as set forth in Section 4.09(c) of the STC Disclosure Schedule,
neither STC nor any STC Subsidiary is a party to any collective bargaining or
other labor union contract applicable to persons employed by STC or any STC
Subsidiary and no collective bargaining agreement is being negotiated by STC
or any STC Subsidiary. As of the date of this Agreement, there is no labor
dispute, strike or work stoppage against STC or any STC Subsidiary pending or,
to the knowledge of STC, threatened which may interfere with the respective
business activities of STC or any STC Subsidiary, except where such dispute,
strike or work stoppage could not reasonably be expected to have, individually
or in the aggregate, an STC Material Adverse Effect. As of the date of this
Agreement, to the knowledge of STC, none of STC, any STC Subsidiary, or any of
their respective representatives or employees has committed any unfair labor
practice in connection with the operation of the respective businesses of STC
or any STC Subsidiary, and there is no charge or complaint against STC or any
STC Subsidiary by the National Labor Relations Board or any comparable
Governmental Entity pending or threatened in writing, except where such unfair
labor practice, charge or complaint could not reasonably be expected to have,
individually or in the aggregate, an STC Material Adverse Effect.
15
<PAGE>
(d) Except as set forth in Section 4.09(d) of the STC Disclosure Schedule,
STC has delivered to CGI true, complete and correct copies of (i) all
employment agreements with officers and employees and all consulting
agreements of STC and each STC Subsidiary providing for annual compensation in
excess of $25,000, (ii) all severance plans, agreements, programs and policies
of STC and each STC Subsidiary with or relating to their respective employees
or consultants, and (iii) all plans, programs, agreements and other
arrangements of STC and each STC Subsidiary with or relating to their
respective employees or consultants which contain "change of control"
provisions.
(e) Except as provided in Section 4.09(e) of the STC Disclosure Schedule or
as otherwise required by Law, no STC Benefit Plan provides retiree medical or
retiree life insurance benefits to any person.
SECTION 4.10. Tax Matters. Except as disclosed in the STC Reports, neither
STC nor, to the knowledge of STC, any of its affiliates has taken or agreed to
take any action (other than actions contemplated by this Agreement) that could
reasonably be expected to prevent the Merger from constituting a transaction
qualifying under Section 368 of the Code. STC is not aware of any agreement,
plan or other circumstance that could reasonably be expected to prevent the
Merger from so qualifying under Section 368 of the Code.
SECTION 4.11. Contracts; Debt Instruments. Except as disclosed in the STC
Reports or in Section 4.11 of the STC Disclosure Schedule, there is no
contract or agreement that is material to the business, financial condition or
results of operations of STC and the STC Subsidiaries taken as a whole (each,
an "STC Material Contract"). Except as disclosed in the STC Reports or in
Section 4.11 of the STC Disclosure Schedule, neither STC nor any STC
Subsidiary is in violation of or in default under (nor does there exist any
condition which with the passage of time or the giving of notice could
reasonably be expected to cause such a violation of or default under) any loan
or credit agreement, note, bond, mortgage, indenture or lease, or any other
contract, license, agreement, arrangement or understanding to which it is a
party or by which it or any of its properties or assets is bound, except for
violations or defaults that could not reasonably be expected to have,
individually or in the aggregate, an STC Material Adverse Effect. Set forth in
Section 4.11 of the STC Disclosure Schedule is a description of any material
changes to the amount and terms of the indebtedness of STC and its
subsidiaries as described in the notes to the financial statements
incorporated in STC 1996 10-K.
SECTION 4.12. Litigation. Except as disclosed in the STC Reports or in
Section 4.12 of the STC Disclosure Schedule, there is no suit, claim, action,
proceeding or investigation pending or, to the knowledge of STC, threatened
against STC or any STC Subsidiary before any Governmental Entity that could
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect, and, except as disclosed to CGI, to the knowledge of
STC, there are no existing facts or circumstances that could reasonably be
expected to result in such a suit, claim, action, proceeding or investigation.
For purposes hereof, nonmeritorious strike-suit litigation challenging the
execution, adoption or performance of this Agreement shall not be deemed
material. Except as disclosed to CGI, STC is not aware of any facts or
circumstances which could reasonably be expected to result in the denial of
insurance coverage under policies issued to STC and the STC Subsidiaries in
respect of such suits, claims, actions, proceedings and investigations, except
in any case as could not reasonably be expected to have, individually or in
the aggregate, an STC Material Adverse Effect. Except as disclosed in the STC
Reports or in Section 4.12 of the STC Disclosure Schedule, neither STC nor any
STC Subsidiary is subject to any outstanding order, writ, injunction or decree
which could reasonably be expected to have, individually or in the aggregate,
an STC Material Adverse Effect.
SECTION 4.13. Environmental Matters. Except as disclosed in the STC Reports
or in Section 4.13 of the STC Disclosure Schedule or as could not reasonably
be expected to have, individually or in the aggregate, an STC Material Adverse
Effect, (i) STC and the STC Subsidiaries are in compliance with all applicable
Environmental Laws; (ii) all past noncompliance of STC or any STC Subsidiary
with Environmental Laws or Environmental Permits has been resolved without any
pending, ongoing or future obligation, cost or liability; and (iii) neither
STC nor any STC Subsidiary has released a Hazardous Material at, or
transported a Hazardous Material to or from, any real property currently or
formerly owned, leased or occupied by STC or any STC Subsidiary, in violation
of any Environmental Law.
16
<PAGE>
SECTION 4.14. Intellectual Property. Except as set forth in Section 4.14 of
the STC Disclosure Schedule, or as could not reasonably be expected to have,
individually or in the aggregate, an STC Material Adverse Effect, STC and the
STC Subsidiaries own or possess adequate licenses or other valid rights to use
all patents, patent rights, trademarks, trademark rights, trade names, trade
dress, trade name rights, copyrights, service marks, trade secrets,
applications for trademarks and for service marks, know-how and other
proprietary rights and information used or held for use in connection with the
respective businesses of STC and the STC Subsidiaries as currently conducted,
and STC is unaware of any assertion or claim challenging the validity of any
of the foregoing. Section 4.14 of the STC Disclosure Schedule lists all
licenses, sublicenses and other agreements to which STC or any STC Subsidiary
is a party and pursuant to which (i) any third party is authorized to use any
intellectual property right of STC or any STC Subsidiary and (ii) STC or any
STC Subsidiary is authorized to use any intellectual property rights (other
than pursuant to shrink-wrap licenses and noncustomized software licenses) of
a third party, and includes the identity of all parties thereto, a description
of the nature and subject matter thereof, the royalty provisions, if any,
therein and the term thereof. Except as set forth in Section 4.14 of the STC
Disclosure Schedule, the conduct of the respective businesses of STC and the
STC Subsidiaries as currently conducted does not conflict in any way with any
patent, patent right, license, trademark, trademark right, trade dress, trade
name, trade name right, service mark or copyright of any third party that
could not reasonably be expected to have, individually or in the aggregate, an
STC Material Adverse Effect. To the knowledge of STC, there are no
infringements of any proprietary rights owned by or licensed by or to STC or
any STC Subsidiary that could reasonably be expected to have, individually or
in the aggregate, an STC Material Adverse Effect.
SECTION 4.15. Taxes. Except as set forth in Section 4.15 of the STC
Disclosure Schedule and except for such matters as could not reasonably be
expected to have, individually or in the aggregate, an STC Material Adverse
Effect, (i) each of STC and each STC Subsidiary has timely filed or shall
timely file all returns and reports required to be filed by it with any taxing
authority with respect to Taxes for any period ending on or before the
Effective Time, taking into account any extension of time to file granted to
or obtained on behalf of STC and the STC Subsidiaries, (ii) all Taxes shown to
be payable on such returns or reports that are due prior to the Effective Time
have been or will be paid, (iii) as of the date hereof, no deficiency for any
amount of Tax has been asserted or assessed by a taxing authority against STC
or any STC Subsidiary and (iv) each of STC and each STC Subsidiary has
provided adequate reserves in its financial statements for any Taxes that have
not been paid, whether or not shown as being due on any returns.
SECTION 4.16. Opinion of Financial Advisor. DLJ has delivered to the board
of directors of STC its written opinion to the effect that, as of the date
hereof, the Common Exchange Ratio, the Series A Exchange Ratio and the Series
B Exchange Ratio to be offered to the stockholders of STC in the proposed
transaction are fair to such stockholders from a financial point of view. DLJ
has authorized the inclusion of its opinion in the Joint Proxy Statement.
SECTION 4.17. Brokers. No broker, finder or investment banker (other than
DLJ) is entitled to any brokerage, finder's or other fee or commission in
connection with the Merger based upon arrangements made by or on behalf of
STC. STC has heretofore made available to CGI true, complete and correct
copies of all agreements between STC and DLJ pursuant to which such firm would
be entitled to any payment relating to the Merger.
SECTION 4.18. Certain Interests. (a) Except as set forth in Section 4.18(a)
of the STC Disclosure Schedule, no officer or director (excluding outside
directors) of STC or any STC Subsidiary, and no relative or spouse (or
relative of such spouse) who resides with, or is a dependent of, any such
officer or director:
(i) has any direct or indirect financial interest in any competitor of
STC; provided, however, that the ownership of securities representing no
more than two percent of the outstanding voting power of any competitor,
supplier or customer, and which are also listed on any national securities
exchange or traded actively in the national over-the-counter market, shall
not be deemed to be a "financial interest" so long as the person owning
such securities has no other connection or relationship with such
competitor, supplier or customer;
17
<PAGE>
(ii) owns, directly or indirectly, in whole or in part, or has any other
interest, in any tangible or intangible property which STC or any STC
Subsidiary uses in the conduct of its business or otherwise; or
(iii) has outstanding any indebtedness to STC or any STC Subsidiary.
(b) Except as set forth in Section 4.18(b) of the STC Disclosure Schedule,
neither STC nor any STC Subsidiary has any liability or any other obligation
of any nature whatsoever to any officer, director or shareholder of STC or any
STC Subsidiary, or to any relative or spouse (or relative of such spouse) who
resides with, or is a dependent of, any such officer, director or shareholder,
other than immaterial liabilities and obligations incurred in the ordinary
course of business which are reflected in the STC Reports or with respect to
which adequate reserves have been taken.
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF CGI AND MERGER SUB
CGI and Merger Sub hereby jointly and severally represent and warrant to STC
that:
SECTION 5.01. Organization and Qualification; Subsidiaries. Each of CGI,
Merger Sub and each other subsidiary of CGI (the "CGI Subsidiaries") has been
duly organized and is validly existing and in good standing (to the extent
applicable) under the laws of the jurisdiction of its incorporation or
organization, as the case may be, and has the requisite corporate power and
authority and all necessary governmental approvals to own, lease and operate
its properties and to carry on its business as it is now being conducted,
except where the failure to be so organized, existing or in good standing or
to have such power, authority and governmental approvals could not reasonably
be expected to have, individually or in the aggregate, a CGI Material Adverse
Effect. Each of CGI, Merger Sub and each other CGI Subsidiary is duly
qualified or licensed to do business, and is in good standing (to the extent
applicable), in each jurisdiction where the character of the properties owned,
leased or operated by it or the nature of its business makes such
qualification or licensing necessary, except for such failures to be so
qualified or licensed and in good standing that could not reasonably be
expected to have, individually or in the aggregate, a CGI Material Adverse
Effect.
SECTION 5.02. Certificate of Incorporation and By-laws. Except as set forth
in Section 5.02 of the CGI Disclosure Schedule, the copies of CGI's
certificate of incorporation and by-laws that are incorporated by reference as
exhibits to CGI's Form 10-K for the period ending December 31, 1995 (the "CGI
1995 10-K") are true, complete and correct copies thereof. CGI has heretofore
furnished STC with true, complete and correct copies of the certificate of
incorporation and by-laws of Merger Sub. Such certificates of incorporation
and by-laws are in full force and effect. Neither CGI nor Merger Sub is in
violation of any of the provisions of its certificate of incorporation or by-
laws.
SECTION 5.03. Capitalization. The authorized capital stock of CGI consists
of 25,000,000 shares of CGI Common Stock and 5,000,000 shares of preferred
stock. As of January 10, 1997, (i) 16,516,0099 shares of CGI Common Stock are
issued and outstanding, all of which are validly issued, fully paid and
nonassessable, (ii) no shares of CGI Common Stock are held in the treasury of
STC, (iii) no shares of CGI Common Stock are held by the CGI Subsidiaries,
(iv) 2,363,240 shares of CGI Common Stock are reserved for future issuance
pursuant to employee stock options or stock incentive rights granted under the
CGI Stock Plans and (v) 3,286,703 shares of CGI Common Stock are reserved for
issuance pursuant to the CGI Stock Option Agreement. As of the date hereof,
there are no shares of preferred stock of CGI issued and outstanding. Except
for the CGI Stock Option Agreement, shares of CGI Common Stock issuable
pursuant to the CGI Stock Plans or pursuant to agreements or arrangements
described in Section 5.03 of the CGI Disclosure Schedule, the CGI Rights
issued and issuable pursuant to the CGI Rights Plan, there are no options,
warrants or other rights, agreements, arrangements or commitments of any
character to which CGI is a party or by which CGI is bound relating to the
issued or unissued capital stock of CGI, Merger Sub or any other CGI
Subsidiary or obligating CGI, Merger Sub or any other CGI Subsidiary to issue
or sell any shares of capital stock of, or other equity interests in, CGI,
Merger Sub or any other CGI Subsidiary. All shares of CGI Common Stock subject
to issuance as aforesaid, upon issuance
18
<PAGE>
prior to the Effective Time on the terms and conditions specified in the
instruments pursuant to which they are issuable, will be duly authorized,
validly issued, fully paid and nonassessable. There are no outstanding
contractual obligations of CGI, Merger Sub or any other CGI Subsidiary to
repurchase, redeem or otherwise acquire any shares of CGI Common Stock or any
capital stock of any CGI Subsidiary. Each outstanding share of capital stock
of each CGI Subsidiary is duly authorized, validly issued, fully paid and
nonassessable and each such share owned by CGI or another CGI Subsidiary is
free and clear of all security interests, liens, claims, pledges, options,
rights of first refusal, agreements, limitations on CGI's or such other CGI
Subsidiary's voting rights, charges and other encumbrances of any nature
whatsoever, except where the failure to own such shares free and clear could
not reasonably be expected to have, individually or in the aggregate, a CGI
Material Adverse Effect. Except as set forth in Section 5.03 of the CGI
Disclosure Schedule, there are no material outstanding contractual obligations
of CGI, Merger Sub or any other CGI Subsidiary to provide funds to, or make
any material investment (in the form of a loan, capital contribution or
otherwise) in, any CGI Subsidiary or any other person.
SECTION 5.04. Authority Relative to This Agreement and the CGI Stock Option
Agreement. CGI and Merger Sub have all necessary corporate power and authority
to execute and deliver this Agreement and the CGI Stock Option Agreement, to
perform their respective obligations hereunder and thereunder and to
consummate the transactions contemplated hereby and thereby. The execution and
delivery of this Agreement and the CGI Stock Option Agreement by CGI and
Merger Sub and the consummation by CGI and Merger Sub of the transactions
contemplated hereby and thereby have been duly and validly authorized by all
necessary corporate action, and no other corporate proceedings on the part of
CGI or Merger Sub are necessary to authorize this Agreement or the CGI Stock
Option Agreement or to consummate such transactions (other than the approval
of this Agreement and the Merger by the holders of a majority of the votes
cast by CGI's stockholders with respect thereto at the CGI Stockholders'
Meeting and the filing and recordation of the Certificate of Merger as
required by the General Corporation Law). This Agreement and the CGI Stock
Option Agreement have been duly executed and delivered by CGI and Merger Sub
and, assuming the due authorization, execution and delivery by STC, constitute
legal, valid and binding obligations of CGI and Merger Sub, enforceable
against CGI and Merger Sub in accordance with their terms.
SECTION 5.05. No Conflict; Required Filings and Consents. (a) The execution
and delivery of this Agreement and the CGI Stock Option Agreement by CGI and
Merger Sub do not, and the performance by CGI and Merger Sub of their
obligations hereunder and thereunder and the consummation of the Merger will
not, (i) conflict with or violate any provision of the certificate of
incorporation or by-laws of CGI or Merger Sub or any equivalent organizational
documents of any other CGI Subsidiary, (ii) assuming that all consents,
approvals, authorizations and permits described in Section 5.05(b) have been
obtained and all filings and notifications described in Section 5.05(b) have
been made, conflict with or violate any Law applicable to CGI or any other CGI
Subsidiary or by which any property or asset of CGI, Merger Sub or any other
CGI Subsidiary is bound or affected or (iii) except as set forth in Section
5.05(a) of the CGI Disclosure Schedule, result in any breach of or constitute
a default (or an event which with the giving of notice or lapse of time or
both could reasonably be expected to become a default) under, or give to
others any right of termination, amendment, acceleration or cancellation of,
or result in the creation of a lien or other encumbrance on any property or
asset of CGI, Merger Sub or any other CGI Subsidiary pursuant to, any note,
bond, mortgage, indenture, contract, agreement, lease, license, permit,
franchise or other instrument or obligation, except, with respect to clauses
(ii) and (iii), for any such conflicts, violations, breaches, defaults or
other occurrences which could not reasonably be expected, individually or in
the aggregate, (A) to have a CGI Material Adverse Effect or (B) to prevent or
materially delay the performance by CGI or Merger Sub of its obligations
pursuant to this Agreement or the CGI Stock Option Agreement or the
consummation of the Merger.
(b) The execution and delivery of this Agreement and the CGI Stock Option
Agreement by CGI and Merger Sub do not, and the performance by CGI and Merger
Sub of their respective obligations hereunder and thereunder and the
consummation of the Merger will not, require any consent, approval,
authorization or permit of, or filing by CGI or Merger Sub with or
notification by CGI or Merger Sub to, any Governmental Entity, except (i)
pursuant to applicable requirements of the Exchange Act, the Securities Act,
Blue Sky Laws, the rules
19
<PAGE>
and regulations of the NASD, state takeover laws, the premerger notification
requirements of the HSR Act, if any, and the filing and recordation of the
Certificate of Merger as required by the General Corporation Law and (ii)
where failure to obtain such consents, approvals, authorizations or permits,
or to make such filings or notifications, could not reasonably be expected,
individually or in the aggregate, (A) to have a CGI Material Adverse Effect or
(B) to prevent or materially delay the performance by CGI or Merger Sub of its
obligations pursuant to this Agreement or the CGI Stock Option Agreement or
the consummation of the Merger.
SECTION 5.06. Permits; Compliance with Laws. (a) Each of CGI, Merger Sub and
each other CGI Subsidiary is in possession of all franchises, grants,
authorizations, licenses, establishment registrations, product listings,
permits, easements, variances, exceptions, consents, certificates, approvals
and orders of any Governmental Entity, including, without limitation, the FDA,
the DEA and similar authorities in other jurisdictions, necessary for it to
own, lease and operate its properties or to store, distribute and market its
products or otherwise to carry on its business as it is now being conducted
(the "CGI Permits"), except where the failure to have, or the suspension or
cancellation of, any of the CGI Permits could not reasonably be expected to
have, individually or in the aggregate, a CGI Material Adverse Effect, and, as
of the date of this Agreement, no suspension or cancellation of any of the CGI
Permits is pending or, to the knowledge of CGI, threatened, except where the
failure to have, or the suspension or cancellation of, any of the CGI Permits
could not reasonably be expected to have, individually or in the aggregate, a
CGI Material Adverse Effect. None of CGI, Merger Sub or any other CGI
Subsidiary is in conflict with, or in default or violation of, (i) any Law
applicable to CGI, Merger Sub or any other CGI Subsidiary or by which any
property or asset of CGI, Merger Sub or any other CGI Subsidiary is bound or
affected or (ii) any CGI Permits, except in the case of clauses (i) and (ii)
for any such conflicts, defaults or violations that could not reasonably be
expected to have, individually or in the aggregate, a CGI Material Adverse
Effect.
(b) Except as disclosed in the CGI Reports or in Section 5.06(b) of the CGI
Disclosure Schedule or as could not reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect:
(i) to the knowledge of CGI, all of the clinical studies which have been,
or are being, conducted by or for CGI and the CGI Subsidiaries are being
conducted in substantial compliance with generally accepted good clinical
practices and all applicable government regulatory requirements; and
(ii) to the knowledge of CGI, none of CGI, the CGI Subsidiaries or any of
their respective officers, employees or agents (during the term of such
person's employment by CGI or any CGI Subsidiary or while acting as an
agent of CGI or any CGI Subsidiary, or, to CGI's knowledge, prior to such
employment) has made any untrue statement of a material fact or fraudulent
statement to the FDA or any similar Governmental Entity, failed to disclose
a material fact required to be disclosed to the FDA or similar Governmental
Entity, or committed an act, made a statement or failed to make a statement
that could reasonably be expected to provide a basis for the FDA or similar
Governmental Entity to invoke its policy respecting "Fraud, Untrue
Statements of Material Facts, Bribery, and Illegal Gratuities" or similar
governmental policy or Law.
SECTION 5.07. SEC Filings; Financial Statements. (a) Except as disclosed in
Section 5.07 of the CGI Disclosure Schedule, CGI has timely filed all forms,
reports and documents required to be filed by it with the SEC and the NASD
since December 31, 1993 through the date of this Agreement (collectively and
as amended, the "CGI Reports"). Each CGI Report (i) was prepared in accordance
with the requirements of the Securities Act, the Exchange Act or the NASD, as
the case may be, and (ii) did not at the time it was filed contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements made therein, in
the light of the circumstances under which they were made, not misleading. No
CGI Subsidiary is subject to the periodic reporting requirements of the
Exchange Act or required to file any form, report or other document with the
SEC, the NASD, any other stock exchange or any other comparable Governmental
Entity.
(b) Each of the consolidated financial statements (including, in each case,
any notes thereto) contained in the CGI Reports was prepared in accordance
with U.S. GAAP applied on a consistent basis throughout the periods indicated
(except as may be indicated in the notes thereto) and each presented fairly,
in all material
20
<PAGE>
respects, the consolidated financial position of CGI and the consolidated CGI
Subsidiaries as at the respective dates thereof and for the respective periods
indicated therein, except as otherwise noted therein (subject, in the case of
unaudited statements, to normal and recurring year-end adjustments which did
not and could not reasonably be expected to have, individually or in the
aggregate, a CGI Material Adverse Effect).
(c) Except as and to the extent set forth or reserved against on the
consolidated balance sheet of CGI and its Subsidiaries as reported in the CGI
Reports, including the notes thereto, none of CGI or any CGI Subsidiary has
any liabilities or obligations of any nature (whether accrued, absolute,
contingent or otherwise) that would be required to be reflected on a balance
sheet or in notes thereto prepared in accordance with U.S. GAAP, except for
liabilities or obligations incurred in the ordinary course of business
consistent with past practice since December 31, 1995 that have not had and
could not reasonably be expected to have, individually or in the aggregate, a
CGI Material Adverse Effect.
SECTION 5.08. Absence of Certain Changes or Events. Since December 31, 1995,
except as contemplated by or as disclosed in this Agreement, as set forth in
Section 5.08 of the CGI Disclosure Schedule or as disclosed in any CGI Report
filed since December 31, 1995, CGI and the CGI Subsidiaries have conducted
their businesses only in the ordinary course consistent with past practice
and, since such date, there has not been (i) any CGI Material Adverse Effect
excluding any changes and effects resulting from changes in economic,
regulatory or political conditions or changes in conditions generally
applicable to the industries in which CGI and the CGI Subsidiaries are
involved, (ii) any event that could reasonably be expected to prevent or
materially delay the performance of their obligations pursuant to this
Agreement and the consummation of the Merger by Merger Sub, (iii) any material
change by CGI in its accounting methods, principles or practices, (iv) any
declaration, setting aside or payment of any dividend or distribution in
respect of the shares of CGI Common Stock or any redemption, purchase or other
acquisition of any of CGI's securities or (v) any increase in the compensation
or benefits or establishment of any bonus, insurance, severance, deferred
compensation, pension, retirement, profit-sharing, stock option (including,
without limitation, the granting of stock options, stock appreciation rights,
performance awards or restricted stock awards), stock purchase or other
employee benefit plan, or any other increase in the compensation payable or to
become payable to any executive officers of CGI or any CGI Subsidiary except
in the ordinary course of business consistent with past practice.
SECTION 5.09. Employee Benefit Plans; Labor Matters. (a) With respect to
each employee benefit plan, program, arrangement and contract (including,
without limitation, any "employee benefit plan", as defined in Section 3(3) of
ERISA) maintained or contributed to by CGI or any CGI Subsidiary, or with
respect to which CGI or any CGI Subsidiary could incur liability under Section
4069, 4212(c) or 4204 of ERISA (the "CGI Benefit Plans", CGI has delivered or
made available to STC a true, complete and correct copy of (i) such CGI
Benefit Plan and the most recent summary plan description related to such CGI
Benefit Plan, if a summary plan description is required therefor, (ii) each
trust agreement or other funding arrangement relating to such CGI Benefit
Plan, (iii) the most recent annual report (Form 5500) filed with the IRS with
respect to such CGI Benefit Plan, (iv) the most recent actuarial report or
financial statement relating to such CGI Benefit Plan and (v) the most recent
determination letter issued by the IRS with respect to such CGI Benefit Plan,
if it is qualified under Section 401(a) of the Code.
(b) Each CGI Benefit Plan has been administered in all material respects in
accordance with its terms and all contributions required to be made under the
terms of any of the CGI Benefit Plans as of the date of this Agreement have
been timely made or have been reflected on the most recent consolidated
balance sheet filed or incorporated by reference in the CGI Reports prior to
the date of this Agreement. Except as set forth in Section 5.09(b) of the CGI
Disclosure Schedule, with respect to the CGI Benefit Plans, no event has
occurred and, to the knowledge of CGI, there exists no condition or set of
circumstances in connection with which CGI or any CGI Subsidiary could be
subject to any liability under the terms of such CGI Benefit Plans, ERISA, the
Code or any other applicable Law which could reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect.
(c) Except as set forth in Section 5.09(c) of the CGI Disclosure Schedule,
neither CGI nor any CGI Subsidiary is a party to any collective bargaining or
other labor union contract applicable to persons employed
21
<PAGE>
by CGI or any CGI Subsidiary and no collective bargaining agreement is being
negotiated by CGI or any CGI Subsidiary. As of the date of this Agreement,
there is no labor dispute, strike or work stoppage against CGI or any CGI
Subsidiary pending or, to the knowledge of CGI, threatened which may interfere
with the respective business activities of CGI or any CGI Subsidiary, except
where such dispute, strike or work stoppage could not reasonably be expected
to have, individually or in the aggregate, a CGI Material Adverse Effect. As
of the date of this Agreement, to the knowledge of CGI, none of CGI, any CGI
Subsidiary, or any of their respective representatives or employees has
committed any unfair labor practice in connection with the operation of the
respective businesses of CGI or any CGI Subsidiary, and there is no charge or
complaint against CGI or any CGI Subsidiary by the National Labor Relations
Board or any comparable Governmental Entity pending or threatened in writing,
except where such unfair labor practice, charge or complaint could not
reasonably be expected to have, individually or in the aggregate, a CGI
Material Adverse Effect.
(d) CGI has delivered to STC true, complete and correct copies of (i) all
employment agreements with officers of CGI and each CGI Subsidiary providing
for annual compensation in excess of $25,000, (b) all severance plans,
agreements, programs and policies of CGI and each CGI Subsidiary with or
relating to their respective employees and (iii) all plans, programs,
agreements and other arrangements of CGI and each CGI Subsidiary with or
relating to their respective employees which contain "change of control"
provisions.
(e) Except as provided in Section 5.09(e) of the CGI Disclosure Schedule or
as otherwise required by Law, no CGI Benefit Plan provides retiree medical or
retiree life insurance benefits to any person.
SECTION 5.10. Tax Matters. Except as disclosed in the CGI Reports, neither
CGI nor, to the knowledge of CGI, any of its affiliates has taken or agreed to
take any action (other than actions contemplated by this Agreement) that could
reasonably be expected to prevent the Merger from constituting a transaction
qualifying under Section 368 of the Code. CGI is not aware of any agreement,
plan or other circumstance that could reasonably be expected to prevent the
Merger from so qualifying under Section 368 of the Code.
SECTION 5.11. Contracts; Debt Instruments. Except as disclosed in the CGI
Reports or in Section 5.11 of the CGI Disclosure Schedule, there is no
contract or agreement that is material to the business, financial condition or
results of operations of CGI and the CGI Subsidiaries taken as a whole (each,
a "CGI Material Contract"). Except as disclosed in the CGI Reports or in
Section 5.11 of the CGI Disclosure Schedule, neither CGI nor any CGI
Subsidiary is in violation of or in default under (nor does there exist any
condition which with the passage of time or the giving of notice could
reasonably be expected to cause such a violation of or default under) any loan
or credit agreement, note, bond, mortgage, indenture or lease, or any other
contract, license, agreement, arrangement or understanding to which it is a
party or by which it or any of its properties or assets is bound, except for
violations or defaults that could not reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect. Set forth in
Section 5.11 of the CGI Disclosure Schedule is a description of any material
changes to the amount and terms of the indebtedness of CGI and its
subsidiaries as described in the notes to the financial statements
incorporated in the CGI 1995 10-K.
SECTION 5.12. Litigation. Except as disclosed in the CGI Reports or in
Section 5.12 of the CGI Disclosure Schedule, there is no suit, claim, action,
proceeding or investigation pending or, to the knowledge of CGI, threatened
against CGI or any CGI Subsidiary before any Governmental Entity that could
reasonably be expected to have, individually or in the aggregate, a CGI
Material Adverse Effect, and, except as disclosed to STC, to the knowledge of
CGI, there are no existing facts or circumstances that could reasonably be
expected to result in such a suit, claim, action, proceeding or investigation.
For purposes hereof, nonmeritorious strike-suit litigation challenging the
execution, adoption or performance of this Agreement shall not be deemed
material. Except as disclosed to STC, CGI is not aware of any facts or
circumstances which could reasonably be expected to result in the denial of
insurance coverage under policies issued to CGI and the CGI Subsidiaries in
respect of such suits, claims, actions, proceedings and investigations, except
in any case as could not reasonably be expected to have, individually or in
the aggregate, a CGI Material Adverse Effect. Except as disclosed in the CGI
Reports or in Section 5.12 of the CGI Disclosure Schedule, neither CGI nor any
CGI Subsidiary is subject to any outstanding order, writ, injunction or decree
which could reasonably be expected to have, individually or in the aggregate,
a CGI Material Adverse Effect.
22
<PAGE>
SECTION 5.13. Environmental Matters. Except as disclosed in the CGI Reports
or in Section 5.13 of the CGI Disclosure Schedule or as could not reasonably
be expected to have, individually or in the aggregate, a CGI Material Adverse
Effect, (i) CGI and the CGI Subsidiaries are in compliance with all applicable
Environmental Laws; (ii) all past noncompliance of CGI or any CGI Subsidiary
with Environmental Laws or Environmental Permits has been resolved without any
pending, ongoing or future obligation, cost or liability; and (iii) neither
CGI nor any CGI Subsidiary has released a Hazardous Material at, or
transported a Hazardous Material to or from, any real property currently or
formerly owned, leased or occupied by CGI or any CGI Subsidiary in violation
of any Environmental Law.
SECTION 5.14. Intellectual Property. Except as disclosed in Section 5.14 of
the CGI Disclosure Schedule or as could not reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect, CGI and the
CGI Subsidiaries own or possess adequate licenses or other valid rights to use
all patents, patent rights, trademarks, trademark rights, trade names, trade
dress, trade name rights, copyrights, service marks, trade secrets,
applications for trademarks and for service marks, know-how and other
proprietary rights and information used or held for use in connection with the
respective businesses of CGI and the CGI Subsidiaries as currently conducted,
and CGI is unaware of any assertion or claim challenging the validity of any
of the foregoing. Section 5.14 of the CGI Disclosure Schedule lists all
licenses, sublicenses and other agreements to which CGI or any CGI Subsidiary
is a party and pursuant to which (i) any third party is authorized to use any
intellectual property right of CGI or any CGI Subsidiary and (ii) CGI or any
CGI Subsidiary is authorized to use any intellectual property rights (other
than pursuant to shrink-wrap licenses and noncustomized software licenses) of
a third party, and includes the identity of all parties thereto, a description
of the nature and subject matter thereof, the royalty provisions, if any,
therein and the term thereof. Except as set forth in Section 5.14 of the CGI
Disclosure Schedule, the conduct of the respective businesses of CGI and the
CGI Subsidiaries as currently conducted does not conflict in any way with any
patent, patent right, license, trademark, trademark right, trade dress, trade
name, trade name right, service mark or copyright of any third party that
could reasonably be expected to have, individually or in the aggregate, a CGI
Material Adverse Effect. Except as disclosed in Section 5.14 of the CGI
Disclosure Schedule, to the knowledge of CGI, there are no infringements of
any proprietary rights owned by or licensed by or to CGI or any CGI Subsidiary
that could reasonably be expected to have, individually or in the aggregate, a
CGI Material Adverse Effect.
SECTION 5.15. Taxes. Except as set forth in Section 5.15 of the CGI
Disclosure Schedule and except for such matters as could not reasonably be
expected to have, individually or in the aggregate, a CGI Material Adverse
Effect, (i) each of CGI, Merger Sub and each other CGI Subsidiary has timely
filed or shall timely file all returns and reports required to be filed by it
with any taxing authority with respect to Taxes for any period ending on or
before the Effective Time, taking into account any extension of time to file
granted to or obtained on behalf of CGI, Merger Sub and the other CGI
Subsidiaries, (ii) all Taxes shown to be payable on such returns or reports
that are due prior to the Effective Time have been or will be paid, (iii) as
of the date hereof, no deficiency for any amount of Tax has been asserted or
assessed by a taxing authority against CGI, Merger Sub or any other CGI
Subsidiary and (iv) each of CGI, Merger Sub and each other CGI Subsidiary has
provided adequate reserves in its financial statements for any Taxes that have
not been paid, whether or not shown as being due on any returns.
SECTION 5.16. Opinion of Financial Advisor. Lehman Brothers has delivered to
the board of directors of CGI its written opinion to the effect that, as of
the date hereof, each of the Common Exchange Ratio, the Series A Exchange
Ratio and the Series B Exchange Ratio is fair to the holders of shares of CGI
Common Stock from a financial point of view. Lehman Brothers has authorized
the inclusion of its opinion in the Joint Proxy Statement.
SECTION 5.17. Brokers. No broker, finder or investment banker (other than
Lehman Brothers) is entitled to any brokerage, finder's or other fee or
commission in connection with the Merger based upon arrangements made by or on
behalf of CGI. CGI has heretofore made available to STC true, complete and
correct copies of all agreements between CGI and Lehman Brothers pursuant to
which such firm would be entitled to any payment relating to the Merger.
23
<PAGE>
SECTION 5.18. Certain Interests. (a) Except as set forth in Section 5.18(a)
of the CGI Disclosure Schedule or in the CGI SEC Reports, no officer or
director (excluding outside directors) of CGI or any CGI Subsidiary, and no
relative or spouse (or relative of such spouse) who resides with, or is a
dependent of, any such shareholder, officer or director:
(i) has any direct or indirect financial interest in any competitor;
provided, however, that the ownership of securities representing no more
than two percent of the outstanding voting power of any competitor,
supplier or customer, and which are also listed on any national securities
exchange or traded actively in the national over-the-counter market, shall
not be deemed to be a "financial interest" so long as the person owning
such securities has no other connection or relationship with such
competitor, supplier or customer;
(ii) owns, directly or indirectly, in whole or in part, or has any other
interest in any tangible or intangible property which CGI or any CGI
Subsidiary uses in the conduct of its business or otherwise; or
(iii) has outstanding any indebtedness to CGI or any CGI Subsidiary.
(b) Except as set forth in Section 5.18(b) of the CGI Disclosure Schedule,
neither CGI nor any CGI Subsidiary has any liability or any other material
obligation of any nature whatsoever to any officer or director of CGI or any
CGI Subsidiary, or to any relative or spouse (or relative of such spouse) who
resides with, or is a dependent of, any such officer or director, other than
immaterial liabilities and obligations incurred in the ordinary course of
business which are reflected in the CGI Reports or with respect to which
adequate reserves have been taken.
ARTICLE VI
COVENANTS
SECTION 6.01. Conduct of Business by STC Pending the Closing. STC agrees
that, between the date of this Agreement and the Effective Time, except as set
forth in Section 6.01 of the STC Disclosure Schedule or as expressly
contemplated by any other provision of this Agreement, unless CGI shall
otherwise agree in writing, (x) the respective businesses of STC and the STC
Subsidiaries shall be conducted only in, and STC and the STC Subsidiaries
shall not take any action except in, the ordinary course of business
consistent with past practice and (y) STC shall use all reasonable efforts to
keep available the services of such of the current officers, employees and
consultants of STC and the STC Subsidiaries and to preserve the current
relationships of STC and the STC Subsidiaries with such of the corporate
partners, customers, suppliers and other persons with which STC or any STC
Subsidiary has significant business relations in order to preserve
substantially intact its business organization. By way of amplification and
not limitation, except as set forth in Section 6.01 of the STC Disclosure
Schedule or as expressly contemplated by any other provision of this Agreement
and the STC Stock Option Agreement, neither STC nor any STC Subsidiary shall,
between the date of this Agreement and the Effective Time, directly or
indirectly, do, or agree to do, any of the following without the prior written
consent of CGI, which consent shall not be unreasonably withheld or delayed:
(a) amend or otherwise change its certificate of incorporation or by-laws
or equivalent organizational documents;
(b) issue, sell, pledge, dispose of, grant, transfer, lease, license,
guarantee or encumber, or authorize the issuance, sale, pledge,
disposition, grant, transfer, lease, license or encumbrance of, (i) any
shares of capital stock of STC or any STC Subsidiary of any class, or
securities convertible into or exchangeable or exercisable for any shares
of such capital stock, or any options, warrants or other rights of any kind
to acquire any shares of such capital stock, or any other ownership
interest (including, without limitation, any phantom interest), of STC or
any STC Subsidiary, except for (A) issuances of STC Common Stock pursuant
to options and warrants thereon outstanding on the date hereof and
described in Section 4.03 and (B) issuances of non-cash dividends required
to be made under the terms of the certificate of designation of STC
applicable to the Series A Preferred Stock, or (ii) any property or assets
of STC or any STC Subsidiary;
24
<PAGE>
(c) (i) acquire (including, without limitation, by merger, consolidation,
or acquisition of stock or assets) any interest in any corporation,
partnership, other business organization or person or any division thereof
or any assets, other than acquisitions of assets; (ii) incur any
indebtedness for borrowed money or issue any debt securities or assume,
guarantee or endorse, or otherwise as an accommodation become responsible
for, the obligations of any person for borrowed money; (iii) terminate,
cancel or request any material change in, or agree to any material change
in, any STC Material Contract or enter into any corporate partnering
transaction or similar arrangement or any other contract or agreement
material to the business, results of operations or financial condition of
STC and the STC Subsidiaries taken as a whole; (iv) make or authorize any
capital expenditure, except for capital expenditures not in excess of
$5,000 individually and $50,000 in the aggregate; provided that CGI will
not unreasonably withhold its consent to reasonable expenditures in excess
thereof; or (v) enter into or amend any contract, agreement, commitment or
arrangement that, if fully performed, would not be permitted under this
Section 6.01(c);
(d) declare, set aside, make or pay any dividend or other distribution,
payable in cash, stock, property or otherwise, with respect to any of its
capital stock or the Fletcher Warrant, except that any STC Subsidiary may
pay dividends or make other distributions to STC or any other STC
Subsidiary and may pay noncash dividends required to be made under the
terms of the certificate of designation of STC applicable to the Series A
Preferred Stock;
(e) reclassify, combine, split, subdivide or redeem, purchase or
otherwise acquire, directly or indirectly, any of its capital stock;
(f) increase the compensation payable or to become payable to its
officers, consultants or employees, or grant any rights to severance or
termination pay to, or enter into any employment or severance agreement
which provides benefits upon a change in control of STC that would be
triggered by the Merger with, any director, officer, consultant or other
employee of STC or any STC Subsidiary who is not currently entitled to such
benefits from the Merger, or establish, adopt, enter into or amend any
collective bargaining, bonus, profit-sharing, thrift, compensation, stock
option, restricted stock, pension, retirement, deferred compensation,
employment, termination, severance or other plan, agreement, trust, fund,
policy or arrangement for the benefit of any director, officer, consultant
or employee of STC or any STC Subsidiary, except to the extent required by
applicable Law or the terms of a collective bargaining agreement;
(g) take any action with respect to accounting policies or procedures,
other than actions in the ordinary course of business consistent with past
practice or as required by U.S. GAAP;
(h) make any tax election or settle or compromise any material federal,
state or local United States income tax liability, or any income tax
liability of any other jurisdiction, other than those made in the ordinary
course of business consistent with past practice and those for which
specific reserves have been recorded on the consolidated balance sheet of
STC and the consolidated STC Subsidiaries dated as of June 30, 1996
included in the 1996 STC 10-K and only to the extent of such reserves; or
(i) authorize or enter into any formal or informal agreement or otherwise
make any commitment to do any of the foregoing.
SECTION 6.02. Conduct of Business by CGI Pending the Closing. CGI agrees
that, between the date of this Agreement and the Effective Time, except as set
forth in Section 6.02 of the CGI Disclosure Schedule or as expressly
contemplated by any other provision of this Agreement, unless STC shall
otherwise agree in writing, (x) the respective businesses of CGI and the CGI
Subsidiaries shall be conducted only in, and CGI and the CGI Subsidiaries
shall not take any action except in, the ordinary course of business
consistent with past practice and (y) CGI shall use all reasonable efforts to
keep available the services of such of the current officers, significant
employees and consultants of CGI and the CGI Subsidiaries and to preserve the
current relationships of CGI and the CGI Subsidiaries with such of the
corporate partners, customers, suppliers and other persons with which CGI or
any CGI Subsidiary has significant business relations as CGI deems reasonably
necessary in order to preserve substantially intact its business organization.
By way of amplification and not limitation, except as set forth in Section
6.02 of the CGI Disclosure Schedule or as expressly contemplated by any other
provision of this
25
<PAGE>
Agreement and the CGI Stock Option Agreement, neither CGI nor any CGI
Subsidiary shall, between the date of this Agreement and the Effective Time,
directly or indirectly, do, or agree to do, any of the following without the
prior written consent of STC, which consent shall not be unreasonably withheld
or delayed:
(a) amend or otherwise change its certificate of incorporation or by-laws
or equivalent organizational documents;
(b) issue, sell, pledge, dispose of, grant, transfer, lease, license,
guarantee or encumber, or authorize the issuance, sale, pledge,
disposition, grant, transfer, lease, license or encumbrance of, (i) any
shares of capital stock of CGI or any CGI Subsidiary of any class, or
securities convertible into or exchangeable or exercisable for any shares
of such capital stock, or any options, warrants or other rights of any kind
to acquire any shares of such capital stock, or any other ownership
interest (including, without limitation, any phantom interest), of CGI or
any CGI Subsidiary, except for (A) issuances of CGI Common Stock pursuant
to options and warrants thereon outstanding on the date hereof and
described in Section 5.03, (B) issuances of options to new hires of CGI and
(C) issuances of options to employees, officers and directors of CGI
consistent with past practice, or (ii) any property or assets of CGI or any
CGI Subsidiary, except in the ordinary course of business consistent with
past practice and pursuant to any existing CGI Material Contract or in an
aggregate amount not in excess of $10,000,000;
(c) (i) acquire (including, without limitation, by merger, consolidation
or acquisition of stock or assets) any interest in any corporation,
partnership, other business organization or person or any division thereof
or any assets, other than acquisitions of assets (excluding the acquisition
of a business or substantially all of the stock or assets thereof) in the
ordinary course of business consistent with past practice, and any
acquisitions for consideration, calculated as of the date of execution of
the definitive agreement for any such acquisition, that is not, in the
aggregate for all such acquisitions, in excess of 10 percent of the market
value of CGI of the date of the execution of any contract related thereto;
(ii) incur any indebtedness for borrowed money or issue any debt securities
or assume, guarantee or endorse, or otherwise as an accommodation become
responsible for, the obligations of any person for borrowed money; (iii)
terminate, cancel or request any material change in, or agree to any
material change in, any CGI Material Contract or enter into any contract or
agreement material to the business, results of operations or financial
condition of CGI and the CGI Subsidiaries taken as a whole, in either case
other than in the ordinary course of business consistent with past
practice; (iv) make or authorize any capital expenditure, other than
capital expenditures in the ordinary course of business consistent with
past practice; or (v) enter into or amend any contract, agreement,
commitment or arrangement that, if fully performed, would not be permitted
under this Section 6.02(c);
(d) declare, set aside, make or pay any dividend or other distribution,
payable in cash, stock, property or otherwise, with respect to any of its
capital stock, except that any CGI Subsidiary may pay dividends or make
other distributions to CGI or any other CGI Subsidiary;
(e) reclassify, combine, split, subdivide or redeem, purchase or
otherwise acquire, directly or indirectly, any of its capital stock;
(f) increase the compensation payable or to become payable to its
officers or employees, except for increases in accordance with past
practices in salaries or wages of employees or officers of CGI or any CGI
Subsidiary (including, without limitation, annual merit increases and
bonuses), or grant any rights to severance or termination pay to, or enter
into any employment or severance agreement which provides benefits upon a
change in control of CGI that would be triggered by the Merger with, any
director, officer or other employee of CGI or any CGI Subsidiary who is not
currently entitled to such benefits upon the Merger, or establish, adopt,
enter into or amend any collective bargaining, bonus, profit-sharing,
thrift, compensation, stock option, restricted stock, pension, retirement,
deferred compensation, employment, termination, severance or other plan,
agreement, trust, fund, policy or arrangement for the benefit of any
director, officer or employee of CGI or any CGI Subsidiary, except to the
extent required by applicable Law or the terms of a collective bargaining
agreement;
(g) take any action with respect to accounting policies or procedures,
other than actions in the ordinary course of business consistent with past
practice or as required by U.S. GAAP;
26
<PAGE>
(h) make any tax election or settle or compromise any material federal,
state or local United States income tax liability, or any income tax
liability of any other jurisdiction, other than those made in the ordinary
course of business consistent with past practice and those for which
specific reserves have been recorded on the consolidated balance sheet of
CGI and the consolidated CGI Subsidiaries dated as of December 31, 1995
included in the 1995 CGI 10-K and only to the extent of such reserves; or
(i) authorize or enter into any formal or informal agreement or otherwise
make any commitment to do any of the foregoing.
SECTION 6.03. Cooperation; Steering Committee. Upon the execution and
delivery of this Agreement, CGI and STC shall establish a committee (the
"Steering Committee") for the purpose of, to the extent permitted by
applicable Laws, facilitating the efficient transition and combination of the
respective businesses of CGI and STC as promptly as practicable following the
Effective Time. The Steering Committee shall consist of up to 10 individuals
to be designated from time to time by the Chairman of CGI in consultation with
the Chairman of STC, and shall be chaired by CGI. The Steering Committee shall
be dissolved as of the Effective Time.
SECTION 6.04. Notices of Certain Events. Each of CGI and STC shall give
prompt notice to the other of (i) any notice or other communication from any
person alleging that the consent of such person is or may be required in
connection with the Merger; (ii) any notice or other communication from any
Governmental Entity in connection with the Merger; (iii) any actions, suits,
claims, investigations or proceedings commenced or, to its knowledge,
threatened against, relating to or involving or otherwise affecting CGI, STC,
the CGI Subsidiaries or the STC Subsidiaries that relate to the consummation
of the Merger; (iv) the occurrence of a default or event that, with the giving
of notice or lapse of time or both, will become a default under any STC
Material Contract or CGI Material Contract; and (v) any change that could
reasonably be expected to have an STC Material Adverse Effect or a CGI
Material Adverse Effect or to delay or impede the ability of either STC or CGI
to perform its obligations pursuant to this Agreement, the STC Stock Option
Agreement or the CGI Stock Option Agreement and to effect the consummation of
the Merger.
SECTION 6.05. Access to Information; Confidentiality. (a) Except as required
pursuant to any confidentiality agreement or similar agreement or arrangement
to which CGI or STC or any of the CGI Subsidiaries or the STC Subsidiaries is
a party or pursuant to applicable Law or the regulations or requirements of
any stock exchange or other regulatory organization with whose rules a party
hereto is required to comply, from the date of this Agreement to the Effective
Time, CGI and STC shall (and shall cause the CGI Subsidiaries and the STC
Subsidiaries, respectively, to) (i) provide to the other (and its officers,
directors, employees, accountants, consultants, legal counsel, agents and
other representatives (collectively, "Representatives")) access at reasonable
times upon prior notice to its and its subsidiaries' officers, employees,
agents, properties, offices and other facilities and to the books and records
thereof, and (ii) furnish promptly such information concerning its and its
subsidiaries' business, properties, contracts, assets, liabilities and
personnel as the other party or its Representatives may reasonably request. No
investigation conducted pursuant to this Section 6.05 shall affect or be
deemed to modify any representation or warranty made in this Agreement.
(b) The parties hereto shall comply with, and shall cause their respective
Representatives to comply with, all of their respective obligations under the
Confidentiality Agreement with respect to the information disclosed pursuant
to this Section 6.05.
SECTION 6.06. No Solicitation of Transactions. Each party to this Agreement
shall not, directly or indirectly, and shall instruct its officers, directors,
employees, subsidiaries, agents or advisors or other representatives
(including, without limitation, any investment banker, attorney or accountant
retained by it), not to, directly or indirectly, solicit, initiate or
knowingly encourage (including by way of furnishing nonpublic information), or
take any other action knowingly to facilitate, any inquiries or the making of
any proposal or offer (including, without limitation, any proposal or offer to
its stockholders) that constitutes, or may reasonably be expected to lead to,
any Competing Transaction, or enter into or maintain or continue discussions
or negotiate with any person in furtherance of such inquiries or to obtain a
Competing Transaction, or agree to or endorse
27
<PAGE>
any Competing Transaction, or authorize or permit any of the officers,
directors or employees of such party or any of its subsidiaries, or any
investment banker, financial advisor, attorney, accountant or other
representative retained by such party or any of such party's subsidiaries, to
take any such action; provided, however, that nothing contained in this
Section 6.06 shall prohibit the board of directors of CGI or STC from (i)
complying with Rule 14e-2 promulgated under the Exchange Act with regard to a
tender or exchange offer or (ii) after receiving the advice of outside counsel
to the effect that the board of directors of STC or CGI, as the case may be,
is required to do so in order to discharge properly its fiduciary duties,
considering, negotiating and approving and recommending to the shareholders of
STC or CGI, as the case may be, an unsolicited bona fide written acquisition
proposal which (A) was not received in violation of this Section 6.06, (B) if
executed or consummated would be a Competing Transaction, (C) is not subject
to financing and (D) the board of directors of STC or CGI, as the case may be,
determines in good faith, after consultation with its financial advisors,
would result in a transaction more favorable to STC's or CGI's stockholders,
as the case may be, than the transaction contemplated by this Agreement (any
such acquisition proposal, a "Superior Proposal"). Each party hereto shall
notify the other parties hereto promptly if any proposal or offer, or any
inquiry or contact with any person with respect thereto, regarding such an
acquisition proposal or a Competing Transaction is made. Each party hereto
immediately shall cease and cause to be terminated all existing discussions or
negotiations with any parties conducted heretofore with respect to a Competing
Transaction. None of the parties hereto shall release any third party from, or
waive any provision of, any confidentiality or standstill agreement to which
it is a party. Each party hereto shall use its best efforts to ensure that its
officers, directors, employees and subsidiaries and any investment banker or
other advisor or representative retained by such party are aware of the
restrictions described in this Section 6.06.
SECTION 6.07. Plan of Reorganization. This Agreement is intended to
constitute a "plan of reorganization" within the meaning of Section 1.368-2(g)
of the income tax regulations promulgated under the Code. From and after the
date of this Agreement, each party hereto shall use all reasonable efforts to
cause the Merger to qualify, and shall not, without the prior written consent
of the other parties hereto, knowingly take any actions or cause any actions
to be taken which could reasonably be expected to prevent the Merger from
qualifying, as a reorganization under the provisions of Section 368 of the
Code. In the event that the Merger shall fail to qualify as a reorganization
under the provisions of Section 368 of the Code, then the parties hereto agree
to negotiate in good faith to restructure the Merger in order that shall
qualify as tax-free transaction under the Code. Following the Effective Time,
and consistent with any such consent, neither the Surviving Corporation nor
CGI nor any of their respective affiliates knowingly and voluntarily shall
take any action or cause any action to be taken which could reasonably be
expected to cause the Merger to fail to qualify as a reorganization under
Section 368 of the Code.
SECTION 6.08. Subsequent Financial Statements. Prior to the Effective Time,
each of STC and CGI (i) shall consult with the other prior to making publicly
available its financial results for any period and (ii) shall consult with the
other prior to the filing of, and shall timely file with the SEC, each Annual
Report on Form10-K, Quarterly Report on Form 10-Q and Current Report on Form
8-K required to be filed by such party under the Exchange Act and shall
promptly deliver to the other copies of each such report filed with the SEC.
SECTION 6.09. Control of Operations. Nothing contained in this Agreement
shall give CGI, directly or indirectly, the right to control or direct the
operations of STC and the STC Subsidiaries prior to the Effective Time. Prior
to the Effective Time, each of CGI and STC shall exercise, consistent with the
terms and conditions of this Agreement, complete control and supervision over
its respective operations.
SECTION 6.10. Further Action; Consents; Filings. Upon the terms and subject
to the conditions hereof, each of the parties hereto shall use all reasonable
efforts to (i) take, or cause to be taken, all appropriate action, and do, or
cause to be done, all things necessary, proper or advisable under applicable
Law or otherwise to consummate and make effective the Merger, (ii) obtain from
Governmental Entities any consents, licenses, permits, waivers, approvals,
authorizations or orders required to be obtained or made by CGI, Merger Sub,
STC or the Surviving Corporation or any of their respective subsidiaries in
connection with the authorization, execution and delivery of this Agreement
and the consummation of the Merger and (iii) make all necessary
28
<PAGE>
filings, and thereafter make any other required or appropriate submissions,
with respect to this Agreement and the Merger required under (A) the rules and
regulations of the NASD, (B) the Securities Act, the Exchange Act and any
other applicable federal or state securities Laws, (C) the HSR Act, if any,
and (D) any other applicable Law. The parties hereto shall cooperate and
consult with each other in connection with the making of all such filings,
including by providing copies of all such documents to the nonfiling parties
and their advisors prior to filing, and none of the parties shall file any
such document if any of the other parties shall have reasonably objected to
the filing of such document. No party shall consent to any voluntary extension
of any statutory deadline or waiting period or to any voluntary delay of the
consummation of the Merger at the behest of any Governmental Entity without
the consent and agreement of the other parties hereto, which consent shall not
be unreasonably withheld or delayed.
ARTICLE VII
ADDITIONAL AGREEMENTS
SECTION 7.01. Registration Statement; Joint Proxy Statement. (a) As promptly
as practicable after the execution of this Agreement, CGI and STC shall
jointly prepare and STC and CGI shall file with the SEC a document or
documents that will constitute (i) the prospectus forming part of the
registration statement on Form S-4 of CGI (together with all amendments
thereto, the "Registration Statement"), in connection with the registration
under the Securities Act of the CGI Common Stock to be issued to STC's
stockholders pursuant to the Merger and (ii) the Joint Proxy Statement with
respect to the Merger relating to the special meeting of each of STC's
stockholders (the "STC Stockholders' Meeting") and CGI's stockholders (the
"CGI Stockholders' Meeting") to be held to consider approval of this Agreement
and the Merger contemplated hereby (together with any amendments thereto, the
"Joint Proxy Statement"). Copies of the Joint Proxy Statement shall be
provided to the NASD in accordance with its rules with respect to the NMS.
Each of the parties hereto shall use all reasonable efforts to cause the
Registration Statement to become effective as promptly as practicable after
this date hereof, and, prior to the effective date of the Registration
Statement, the parties hereto shall take all action required under any
applicable Laws in connection with the issuance of shares of CGI Common Stock
pursuant to the Merger. CGI or STC, as the case may be, shall furnish all
information concerning itself as the other party may reasonably request in
connection with such actions and the preparation of the Registration Statement
and Joint Proxy Statement. As promptly as practicable after the effective date
of the Registration Statement, the Joint Proxy Statement shall be mailed to
the stockholders of CGI and STC. Each of the parties hereto shall cause the
Joint Proxy Statement to comply as to form and substance in all material
respects with the applicable requirements of (i) the Exchange Act, (ii) the
Securities Act, (iii) the rules and regulations of the NASD and (iv) the
General Corporation Law.
(b) The Joint Proxy Statement shall include (i)(A) subject to the provisos
contained in the first sentence of Section 6.06, the approval of the Merger
and the STC Amendment and recommendation of the board of directors of STC to
the stockholders of STC that they vote in favor of approval of this Agreement
and the Merger contemplated hereby and the STC Amendment, and (B) the opinion
of DLJ referred to in Section 4.18, and (ii)(A) subject to the provisos
contained in the first sentence of Section 6.06, the approval of the Merger
and the CGI Amendment and recommendation of the board of directors of CGI to
the stockholders of CGI that they vote in favor of approval of this Agreement
and the Merger contemplated hereby and the CGI Amendment, and (B) the opinion
of Lehman Brothers referred to in Section 5.18.
(c) No amendment or supplement to the Joint Proxy Statement or the
Registration Statement shall be made without the approval of CGI and STC,
which approval shall not be unreasonably withheld or delayed. Each of the
parties hereto shall advise the other parties hereto, promptly after it
receives notice thereof, of the time when the Registration Statement has
become effective or any supplement or amendment has been filed, of the
issuance of any stop order, of the suspension of the qualification of the CGI
Common Stock issuable in connection with the Merger for offering or sale in
any jurisdiction, or of any request by the SEC or the NASD for amendment of
the Joint Proxy Statement or the Registration Statement or comments thereon
and responses thereto or requests by the SEC for additional information.
29
<PAGE>
(d) The information supplied by STC for inclusion in the Registration
Statement and the Joint Proxy Statement shall not, at (i) the time the
Registration Statement is filed with the SEC, (ii) if different, the time the
Registration Statement is declared effective, (iii) the time the Joint Proxy
Statement (or any amendment thereof or supplement thereto) is first mailed to
the stockholders of STC and CGI, (iv) the time of the STC Stockholders'
Meeting, (v) the time of the CGI Stockholders' Meeting and (vi) the Effective
Time, contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading. If at any time prior to the Effective Time any event or
circumstance relating to STC or any STC Subsidiary, or their respective
officers or directors, should be discovered by STC that should be set forth in
an amendment or a supplement to the Registration Statement or Joint Proxy
Statement, STC shall promptly inform CGI. All documents that STC is
responsible for filing with the SEC in connection with the Merger will comply
as to form in all material respects with the applicable requirements of the
rules and regulations of the NASD, the General Corporation Law, the Securities
Act and the Exchange Act.
(e) The information supplied by CGI for inclusion in the Registration
Statement and the Joint Proxy Statement shall not, at (i) the time the
Registration Statement is filed with the SEC, (ii) if different, the time the
Registration Statement is declared effective, (iii) the time the Joint Proxy
Statement (or any amendment thereof or supplement thereto) is first mailed to
the stockholders of CGI and STC, (iv) the time of the STC Stockholders'
Meeting, (v) the time of the CGI Stockholders' Meeting and (vi) the Effective
Time, contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading. If, at any time prior to the Effective Time, any event or
circumstance relating to CGI or any CGI Subsidiary, or their respective
officers or directors, should be discovered by CGI that should be set forth in
an amendment or a supplement to the Registration Statement or Joint Proxy
Statement, CGI shall promptly inform STC. All documents that CGI is
responsible for filing with the SEC in connection with the Merger will comply
as to form in all material respects with the applicable requirements of the
rules and regulations of the NASD, the General Corporation Law, the Securities
Act and the Exchange Act.
SECTION 7.02. Stockholders' Meetings. STC shall call and hold the STC
Stockholders' Meeting and CGI shall call and hold the CGI Stockholders'
Meeting as promptly as practicable after the date hereof for the purpose of
voting upon the approval of this Agreement pursuant to the Joint Proxy
Statement and the Merger contemplated hereby, and each of CGI and STC shall
use all reasonable efforts to hold the CGI Stockholders' Meeting and the STC
Stockholders' Meeting on the same day and as soon as practicable after the
date on which the Registration Statement becomes effective. STC shall use all
reasonable efforts to solicit from its stockholders proxies in favor of the
approval of this Agreement and the Merger contemplated hereby and the
Amendment pursuant to the Joint Proxy Statement and shall take all other
action necessary or advisable to secure the vote or consent of stockholders
required by the General Corporation Law or applicable stock exchange
requirements to obtain such approval. CGI shall use all reasonable efforts to
solicit from its stockholders proxies in favor of the approval of this
Agreement and the Merger contemplated hereby pursuant to the Joint Proxy
Statement, and shall take all other action necessary or advisable to secure
the vote or consent of stockholders required by the General Corporation Law or
applicable stock exchange requirements to obtain such approval. Each of the
parties hereto shall take all other action necessary or, in the opinion of the
other parties hereto, advisable to promptly and expeditiously secure any vote
or consent of stockholders required by applicable Law and such party's
certificate of incorporation and by-laws to effect the Merger.
SECTION 7.03. Affiliates. (a) Not fewer than 45 days prior to the Effective
Time, STC shall deliver to CGI a list of names and addresses of each person
who was, in STC's reasonable judgment, at the record date for the STC
Stockholders' Meeting, an affiliate of STC. STC shall provide CGI such
information and documents as CGI shall reasonably request for purposes of
reviewing such list. STC shall use all reasonable efforts to deliver or cause
to be delivered to CGI, prior to the Effective Time, an affiliate agreement in
the form attached hereto as Exhibit 7.03(a) (each, an "STC Affiliate
Agreement"), executed by each of the affiliates of STC identified in the
above-referenced list. The foregoing notwithstanding, CGI shall be entitled to
place legends as specified in the form of STC Affiliate Agreement on the
certificates evidencing any of the CGI Common Stock to be received by
30
<PAGE>
(i) any affiliate of STC or (ii) any person CGI reasonably identifies (by
written notice to STC) as being a person who may be deemed an "affiliate"
within the meaning of Rule 145 promulgated under the Securities Act, and to
issue appropriate stop transfer instructions to the transfer agent for such
CGI Common Stock, consistent with the terms of the form of STC Affiliate
Agreement, regardless of whether such person has executed an STC Affiliate
Agreement and regardless of whether such person's name and address appear on
Section 4.16 of the STC Disclosure Schedule.
(b) CGI shall use all reasonable efforts to obtain or cause to be obtained,
prior to the Effective Time, an affiliate agreement in the form attached
hereto as Exhibit 7.03(b) (each, a "CGI Affiliate Agreement"), executed by
each person who was, in CGI's reasonable judgment, at the record date for the
CGI Stockholders' Meeting, an affiliate of CGI.
SECTION 7.04. Directors' and Officers' Indemnification and
Insurance. (a) The certificate of incorporation and by-laws of the Surviving
Corporation shall contain provisions no less favorable with respect to
indemnification than are set forth in the certificate of incorporation and by-
laws of STC on the date hereof, which provisions shall not be amended,
repealed or otherwise modified for a period of six years from the Effective
Time in any manner that would affect adversely the rights thereunder of
individuals who at the Effective Time were directors, officers, employees,
fiduciaries or agents of STC, unless such modification shall be required by
law.
(b) STC shall, to the fullest extent permitted under applicable law and
regardless of whether the Merger shall become effective, indemnify and hold
harmless, and, after the Effective Time, the Surviving Corporation shall, to
the fullest extent permitted under applicable law, indemnify and hold
harmless, each present and former director, officer, employee, fiduciary and
agent of STC and each STC Subsidiary (collectively, the "Indemnified Parties")
against all costs and expenses (including attorneys' fees), judgments, fines,
losses, claims, damages, liabilities and settlement amounts paid in connection
with any claim, action, suit, proceeding or investigation (whether arising
before or after the Effective Time), whether civil, criminal, administrative
or investigative, arising out of or pertaining to any action or omission in
their capacity as an officer, director, employee, fiduciary or agent, whether
occurring before or after the Effective Time, for a period of six years after
the date hereof. In the event of any such claim, action, suit, proceeding or
investigation, (i) STC or the Surviving Corporation, as the case may be, shall
pay the reasonable fees and expenses of counsel selected by the Indemnified
Parties, which counsel shall be reasonably satisfactory to STC or the
Surviving Corporation, promptly after statements therefor are received and
(ii) STC and the Surviving Corporation shall cooperate in the defense of any
such matter; provided, however, that neither STC nor the Surviving Corporation
shall be liable for any settlement effected without its written consent (which
consent shall not be unreasonably withheld); provided further that neither STC
nor the Surviving Corporation shall be obligated pursuant to this Section
7.04(b) to pay the fees and expenses of more than one counsel for all
Indemnified Parties in any single action; provided further that, in the event
that any claim for indemnification is asserted or made within such six-year
period, all rights to indemnification in respect of such claim shall continue
until the disposition of such claim.
(c) The Surviving Corporation shall use all reasonable efforts to maintain
in effect for three years from the Effective Time, if available, the current
directors' and officers' liability insurance policies maintained by STC
(provided that the Surviving Corporation may substitute therefor policies of
at least the same coverage containing terms and conditions which are not
materially less favorable) with respect to matters occurring prior to the
Effective Time; provided, however, that in no event shall the Surviving
Corporation be required to expend pursuant to this Section 7.04(c) more than
an amount per year equal to 125% of current annual premiums paid by STC for
such insurance.
(d) In the event STC or the Surviving Corporation or any of their respective
successors or assigns (i) consolidates with or merges into any other person
and shall not be the continuing or surviving corporation or entity of such
consolidation or merger or (ii) transfers all or substantially all of its
properties and assets to any person, then, and in each such case, proper
provision shall be made so that the successors and assigns of STC or the
Surviving Corporation, as the case may be, or at CGI's option, CGI, shall
assume the obligations set forth in this Section 7.04.
31
<PAGE>
SECTION 7.05. No Shelf Registration. CGI shall not be required to amend or
maintain the effectiveness of the Registration Statement for the purpose of
permitting resale of the shares of CGI Common Stock received pursuant hereto
by the persons who may be deemed to be "affiliates" of STC or CGI within the
meaning of Rule 145 promulgated under the Securities Act.
SECTION 7.06. Public Announcements. The initial press release concerning the
Merger shall be a joint press release and, thereafter, CGI and STC shall
consult with each other before issuing any press release or otherwise making
any public statements with respect to this Agreement or the Merger and shall
not issue any such press release or make any such public statement without the
prior written approval of the other, except to the extent required by
applicable Law or the requirements of the rules and regulations of the NASD,
in which case the issuing party shall use all reasonable efforts to consult
with the other party before issuing any such release or making any such public
statement.
SECTION 7.07. Officers and Directors of CGI. (a) At the Effective Time,
subject to the certificate of incorporation and by-laws of CGI, Stephen A.
Sherwin, M.D. shall continue to hold the offices of Chairman, President and
Chief Executive Officer of CGI.
(b) Immediately after the Effective Time, the total number of persons
serving on the board of directors of CGI shall be nine (unless otherwise
agreed in writing by STC and CGI prior to the Effective Time), and shall
consist of the following individuals:
David W. Carter
James M. Gower
Raju S. Kucherlapati, Ph.D.
Joseph E. Maroun
John T. Potts, Jr., M.D.
Thomas E. Shenk, Ph.D.
Stephen A. Sherwin, M.D.
Eugene L. Step
Inder M. Verma, Ph.D.
In the event that, prior to the Effective Time, any person so selected to
serve on the board of directors of CGI is unable or unwilling to serve in such
position, the party with which such person was affiliated prior to the date
hereof shall designate another person to serve in such person's stead in
accordance with the provisions of the immediately preceding sentence; provided
that any such designee shall be reasonably satisfactory to each of CGI and
STC. From and after the Effective Time, the composition of the board of
directors shall be determined in accordance with the certificate of
incorporation and by-laws of CGI.
SECTION 7.08. NMS Listing. Each of the parties hereto shall use all
reasonable efforts to obtain, prior to the Effective Time, the approval for
listing on the NMS, effective upon official notice of issuance, of the shares
of CGI Common Stock into which the shares of STC Capital Stock will be
converted pursuant to Article III.
SECTION 7.09. Blue Sky. Each of the parties hereto shall use all reasonable
efforts to obtain, prior to the Effective Time, all necessary blue sky permits
and approvals required under Blue Sky Laws to permit the distribution of the
shares of CGI Common Stock to be issued in accordance with the provisions of
this Agreement.
SECTION 7.10. STC Stock Options. At the Effective Time, CGI shall assume, by
virtue of this Agreement and without any further action on the part of STC,
all of STC's obligations with respect to each outstanding STC Stock Option,
whether vested or unvested. STC shall take all corporate action necessary to
ensure that, unless otherwise elected by CGI prior to the Effective Time, CGI
shall make such assumption in such manner that CGI (i) is a corporation
"assuming a stock option in a transaction to which Section 424(a) applies"
within the meaning of Section 424 of the Code or (ii) to the extent that
Section 424 of the Code does not apply to such STC Stock Option, would be such
a corporation were Section 424 of the Code applicable to such STC Stock
Option; and, if not so otherwise elected, after the Effective Time, all
references to STC in the STC Stock Plans
32
<PAGE>
and the applicable STC Stock Option agreements shall be deemed to refer to
CGI, which shall have assumed the STC Stock Plans as of the Effective Time by
virtue of this Agreement and without any further action on the part of STC or
CGI. Each STC Stock Option so assumed by CGI under this Agreement shall
continue to have, and be subject to, the same terms and conditions set forth
in the applicable STC Stock Plan and the applicable STC Stock Option as in
effect immediately prior to the Effective Time, except as otherwise provided
in Section 3.05. CGI shall use all reasonable efforts to ensure that the STC
Stock Options intended to qualify as incentive stock options under Section 422
of the Code prior to the Effective Time continue to so qualify after the
Effective Time. As soon as practicable after the Effective Time, CGI shall
file with the SEC and use its best efforts to have declared effective a
registration statement on Form S-8 with respect to the shares of CGI Common
Stock issuable under the assumed STC Stock Plans.
SECTION 7.11. [INTENTIONALLY LEFT BLANK]
SECTION 7.12. Bridge Facility. (a) Pursuant to Section 6.01(b), STC is
prohibited from, among other things, exercising the Fletcher Put Options.
(b) During the term of this Agreement, STC shall promptly notify CGI if the
Projected Cash Balances are (i) then forecast by senior management of STC to
fall below $5,000,000 within 30 days or (ii) then below $5,000,000. Such
notice (a "Liquidity Notice") shall include, without limitation, the date on
which the Projected Cash Balances are forecast to fall below $5,000,000. STC
shall use all reasonable efforts to prevent the Actual Balances from falling
below $5,000,000. STC shall borrow under the Bridge Facility to prevent the
Actual Balances from falling below $5,000,000.
(c) Upon receipt of a Liquidity Notice from STC and so long as a Commitment
Termination Event shall not have occurred which reduces the then available
Bridge Facility amount to $0.00, if so requested by STC, CGI shall lend STC
funds under the Bridge Facility as provided in subsection (d) of this Section
7.12 in increments of $50,000. All funds provided to STC under the Bridge
Facility shall be used solely to fund ordinary and necessary operating
expenses in accordance with the then current Operating Budget.
(d) In the event that STC elects or is required to borrow funds pursuant to
subsection (c) of this Section 7.12 and provided that no Commitment
Termination Event shall have occurred which reduces the then available Bridge
Facility amount to $0.00, CGI shall, upon the terms and subject to the
conditions set forth herein and in the Bridge Facility Promissory Note, make
advances (the "Advances") to STC at such times as are reasonably requested
until the earlier to occur of (i) the date on which the then available Bridge
Facility amount equals $0.00 and (ii) June 30, 1997 in an aggregate principal
amount not to exceed at any time outstanding $5,000,000. Each Advance shall be
in an amount of $50,000 or an integral multiple of $50,000 in excess thereof.
Each Advance shall be made upon notice (which notice may be included in a
Liquidity Notice) given by STC to CGI not later than 11:00 a.m. San Francisco
time on the second business day prior to the date of the proposed Advance.
Such notice shall specify the date and amount of the proposed Advance and
identify its intended usage. Not later than 2:00 p.m. San Francisco time on
the date of such Advance and upon fulfillment of the applicable conditions set
forth in subsection (e) of this Section 7.12, CGI shall make such Advance
available to STC in same day funds at STC's address specified above.
(e) (i) The obligation of CGI to make its initial Advance under the Bridge
Facility shall be subject to the conditions precedent that CGI shall have
received, on or before the day of such initial Advance, (A) a certificate of the
Secretary or an Assistant Secretary of STC dated the day of such initial
Advance, in form and substance satisfactory to CGI, certifying (1) copies of the
resolutions of the board of directors of STC approving the Bridge Facility
Promissory Note, and of all documents evidencing other necessary corporate
action and governmental approvals, if any, with respect to the Bridge Facility
Promissory Note, and (2) the names and true signatures of the officers of STC
authorized to sign the Bridge Facility Promissory Note and the other documents
to be delivered hereunder; and (B) a counterpart executed by Somatix of the
security agreement in the form previously agreed between the parties, pursuant
to which Somatix shall grant Cell Genesys a security interest in certain
intellectual property to secure the indebtedness at any time outstanding under
the Bridge Facility.
33
<PAGE>
(ii) The obligation of CGI to make each Advance (including the initial
Advance) shall be subject to the further conditions precedent that (A) this
Agreement shall have been executed and delivered by the parties hereto and
shall be in full force and effect; (B) the representations and warranties
contained in the Bridge Facility Promissory Note shall be, and CGI shall have
received a certificate signed by a duly authorized officer of STC, dated the
date of such Advance, certifying that such representations and warranties are,
true, complete and correct in all material respects on and as of the date of
such Advance, before and after giving effect to such Advance and to the
application of the proceeds therefrom, as though made on and as of such date;
(C) no event shall have occurred and be continuing, or be reasonably likely to
result from such Advance or from the application of the proceeds therefrom,
which constitutes an Event of Default or would constitute an Event of Default
but for the requirement that notice be given or time elapse or both; and (D)
CGI shall have received a certificate signed by a duly authorized officer of
STC, dated the date of such Advance, certifying the then Projected Cash
Balances and Actual Cash Balances.
(f) STC shall, in consultation with the Steering Committee, revise the
Projected Cash Balances and the Operating Budget from time to time, but in no
event less frequently than monthly; provided, however, that in the event STC
delivers to CGI a revised Operating Budget materially adversely different than
the Operating Budget delivered on the date hereof without the prior written
consent of CGI, CGI's obligations under the Bridge Facility shall be suspended
until such time as the parties hereto agree to a revised Operating Budget.
SECTION 7.13. Audited Financial Statements. As soon as practicable after the
date hereof or, in the case of the fiscal quarter of STC ending March 31,
1997, as soon as practicable after March 31, 1997 if CGI does not then
reasonably expect the Effective Time to occur within 45 days of such date, STC
shall cause its independent certified public accountants to prepare and audit
balance sheets of STC at and as of December 31, 1996 and March 31, 1997,
respectively, and related statements of income, retained earnings,
shareholders' equity and changes in financial position of STC for the six-
month period ended December 31, 1996 and the nine-month period ending March
31, 1997, respectively, and to render its unqualified report thereon. Within
one business day of receipt of the above described audited consolidated
financial statements of STC, STC shall deliver to CGI true, complete and
correct copies of such financial statements, together with the auditor's
reports thereon.
SECTION 7.14. Additional Debt. (a) Notwithstanding the restrictions
contained in Section 6.01 and the provisions of the Bridge Facility referred
to in Section 7.12, STC may incur indebtedness in addition to that in effect
on the date hereof in a principal amount not in excess of $2,000,000 if, and
only if, the following conditions shall have been satisfied to the reasonable
satisfaction of CGI on or prior to the date of incurrence of such additional
indebtedness (a transaction meeting all of the following conditions being
referred to as a "Permitted Financing"):
(i) STC shall have given CGI not fewer than two business days' notice of
its intention to enter into an agreement to incur any additional
indebtedness;
(ii) such additional indebtedness shall be unsecured;
(iii) any shares of STC Capital Stock (or warrants, options or similar
securities convertible into or exchangeable for STC Capital Stock) issued
in connection with such additional indebtedness will, by their terms, be
converted into shares of CGI Common Stock pursuant to the Merger; and
(iv) the other terms and conditions thereof shall be reasonably
satisfactory to CGI; provided that any term that creates any right
whatsoever in any asset or property of STC, or any ongoing obligation or
liability on STC or CGI after repayment in full of such additional
indebtedness, shall be conclusively not satisfactory.
(b) All funds provided to STC under any Permitted Financing shall be used
solely to fund ordinary and necessary operating expenses in accordance with
the then current Operating Budget.
34
<PAGE>
ARTICLE VIII
CONDITIONS TO THE MERGER
SECTION 8.01. Conditions to the Obligations of Each Party to Consummate the
Merger. The obligations of the parties hereto to consummate the Merger, or to
permit the consummation of the Merger, are subject to the satisfaction or, if
permitted by applicable Law, waiver of the following conditions:
(a) the Registration Statement shall have been declared effective by the
SEC under the Securities Act and no stop order suspending the effectiveness
of the Registration Statement shall have been issued by the SEC and no
proceeding for that purpose shall have been initiated by the SEC and not
concluded or withdrawn;
(b) (i) this Agreement and the Merger shall have been duly approved by
the requisite vote of the stockholders of each of STC and CGI and (ii) the
CGI Amendment shall have been duly approved by the requisite vote of the
stockholders of CGI, in each case in accordance with the General
Corporation Law;
(c) no court of competent jurisdiction shall have issued or entered any
order, writ, injunction or decree, and no other Governmental Entity shall
have issued any order, which is then in effect and has the effect of making
the Merger illegal or otherwise prohibiting its consummation;
(d) any waiting period (and any extension thereof) applicable to the
consummation of the Merger under the HSR Act or any other applicable
competition, merger control or similar Law shall have expired or been
terminated;
(e) all consents, approvals and authorizations legally required to be
obtained to consummate the Merger shall have been obtained from all
Governmental Entities, except where the failure to obtain any such consent,
approval or authorization could not reasonably be expected to result in a
change in or have an effect on the business of STC or CGI that is
materially adverse to the business, assets (including intangible assets),
liabilities (contingent or otherwise), condition (financial or otherwise)
or results of operations of CGI and its subsidiaries, taken as a whole; and
(f) the shares of CGI Common Stock into which the shares of STC Capital
Stock will be converted pursuant to Article III and the shares of CGI
Common Stock issuable upon the exercise of options pursuant to Section 3.05
shall have been authorized for listing on the NMS, subject to official
notice of issuance.
SECTION 8.02. Conditions to the Obligations of STC. The obligations of STC
to consummate the Merger, or to permit the consummation of the Merger, are
subject to the satisfaction or, if permitted by applicable Law, waiver of the
following further conditions:
(a) each of the representations and warranties of CGI contained in this
Agreement that is qualified by materiality shall be true, complete and
correct at and as of the Effective Time as if made at and as of such time
(other than representations and warranties which address matters only as of
a certain date which shall be true, complete and correct as of such certain
date) and each of the representations and warranties that is not so
qualified shall be true, complete and correct in all material respects at
and as of the Effective Time as if made at and as of such time (other than
representations and warranties which address matters only as of a certain
date which shall be true, complete and correct in all material respects as
of such certain date), in each case except as contemplated or permitted by
this Agreement, and STC shall have received a certificate of the Chairman
or President and Chief Financial Officer of CGI to such effect;
(b) CGI shall have performed or complied in all material respects with
all material agreements and covenants required by this Agreement to be
performed or complied with by it on or prior to the Effective Time and STC
shall have received a certificate of the Chairman or President and Chief
Financial Officer of CGI to that effect; and
35
<PAGE>
(c) Brobeck, Phleger & Harrison, special counsel to STC, shall have
issued its opinion, such opinion dated on or about the date of the Closing,
addressed to STC, and reasonably satisfactory to it, based upon customary
representations of STC and customary assumptions (including delivery and
non-withdrawal of the opinion referred to in subsection (c) of Section
8.03), to the effect that the Merger will be treated for federal income tax
purposes as a reorganization qualifying under the provisions of Section 368
of the Code and that each of STC, Merger Sub and CGI will be a party to the
reorganization within the meaning of Section 368(b) of the Code, which
opinions shall not have been withdrawn or modified in any material respect.
SECTION 8.03. Conditions to the Obligations of CGI. The obligations of CGI
to consummate the Merger, or to permit the consummation of the Merger, are
subject to the satisfaction or, if permitted by applicable Law, waiver of the
following further conditions:
(a) each of the representations and warranties of STC contained in this
Agreement that is qualified by materiality shall be true, complete and
correct at and as of the Effective Time as if made at and as of such time
(other than representations and warranties which address matters only as of
a certain date which shall be true, complete and correct as of such certain
date) and each of the representations and warranties that is not so
qualified shall be true, complete and correct in all material respects at
and as of the Effective Time as if made at and as of such time (other than
representations and warranties which address matters only as of a certain
date which shall be true, complete and correct in all material respects as
of such certain date), in each case except as contemplated or permitted by
this Agreement, and CGI shall have received a certificate of the Chairman
or President and Chief Financial Officer of STC to such effect;
(b) STC shall have performed or complied in all material respects with
all material agreements and covenants required by this Agreement to be
performed or complied with by it on or prior to the Effective Time and CGI
shall have received a certificate of the Chairman or President and Chief
Financial Officer of STC to that effect;
(c) Shearman & Sterling, special counsel to CGI, shall have issued its
opinion, such opinion dated on or about the date of the Closing, addressed
to CGI, and reasonably satisfactory to it, based upon customary
representations of CGI and customary assumptions (including delivery and
non-withdrawal of the opinion referred to in subsection (c) of Section
8.02), to the effect that the Merger will be treated for federal income tax
purposes as a reorganization qualifying under the provisions of Section 368
of the Code and that each of CGI, Merger Sub and STC will be a party to the
reorganization within the meaning of Section 368(b) of the Code, which
opinions shall not have been withdrawn or modified in any material respect;
(d) the STC Amendment shall have been duly approved by the requisite vote
of the stockholders of STC in accordance with the General Corporation Law;
(e) STC shall have executed and delivered the Bridge Facility Promissory
Note; and
(f) the holder(s) of the Fletcher Warrant shall have elected pursuant to
the Fletcher Notice and in accordance with Section 10 of the Fletcher
Warrant either (i) to resell the Fletcher Warrant to STC for cash or (ii)
to permit CGI to assume the Fletcher Warrant pursuant to Section 3.05;
provided, however, that any disagreement between STC and Fletcher as to the
cash amount so required to be paid shall not constitute a failure of this
condition.
36
<PAGE>
ARTICLE IX
TERMINATION, AMENDMENT AND WAIVER
SECTION 9.01. Termination. This Agreement may be terminated and the Merger
may be abandoned at any time prior to the Effective Time, notwithstanding any
requisite adoption and approval of this Agreement, as follows:
(a) by mutual written consent duly authorized by the boards of directors
of each of CGI and STC;
(b) by either CGI or STC, if the Effective Time shall not have occurred
on or before August 31, 1997; provided, however, that the right to
terminate this Agreement under this Section 9.01(b) shall not be available
to any party whose failure to fulfill any obligation under this Agreement
shall have caused, or resulted in, the failure of the Effective Time to
occur on or before such date;
(c) by either CGI or STC, if any Governmental Order, writ, injunction or
decree preventing the consummation of the Merger shall have been entered by
any court of competent jurisdiction and shall have become final and
nonappealable;
(d) by CGI, if (i) the board of directors of STC withdraws, modifies or
changes its recommendation of this Agreement, the Merger or the Amendment
in a manner adverse to CGI or its stockholders or shall have resolved to do
so, (ii) the board of directors of STC shall have recommended to the
stockholders of STC a Competing Transaction or shall have resolved to do so
or (iii) a tender offer or exchange offer for 15 percent or more of the
outstanding shares of capital stock of STC shall have been commenced and
the board of directors of STC shall have failed to recommend against
acceptance of such tender offer or exchange offer by its stockholders
(including by taking no position with respect to the acceptance of such
tender offer or exchange offer by its stockholders);
(e) by STC, if (i) the board of directors of CGI withdraws, modifies or
changes its recommendation of this Agreement or the Merger in a manner
adverse to STC or its stockholders or shall have resolved to do so, (ii)
the board of directors of CGI shall have recommended to the stockholders of
CGI a Competing Transaction or shall have resolved to do so or (iii) a
tender offer or exchange offer for 15 percent or more of the outstanding
shares of capital stock of CGI shall have been commenced and the board of
directors of CGI shall have failed to recommend against acceptance of such
tender offer or exchange offer by its stockholders (including by taking no
position with respect to the acceptance of such tender offer or exchange
offer by its stockholders);
(f) by CGI or STC, if (i) this Agreement and the Merger shall fail to
receive the requisite votes for approval at the STC Stockholders' Meeting
or any adjournment or postponement thereof or (ii) if this Agreement and
the Merger shall fail to receive the requisite votes for approval at the
CGI Stockholders' Meeting or any adjournment or postponement thereof;
(g) by CGI, upon a breach of any representation, warranty, covenant or
agreement on the part of STC set forth in this Agreement, or if any
representation or warranty of STC shall have become untrue, incomplete or
incorrect, in either case such that the conditions set forth in Section
8.03 would not be satisfied (a "Terminating STC Breach"); provided,
however, that, if such Terminating STC Breach is curable by STC through the
exercise of its reasonable efforts within 60 days and for so long as STC
continues to exercise such reasonable efforts, CGI may not terminate this
Agreement under this Section 9.01(g); and provided further that the
preceding proviso shall not in any event be deemed to extend any date set
forth in paragraph (b) of this Section 9.01;
(h) by STC, upon breach of any representation, warranty, covenant or
agreement on the part of CGI set forth in this Agreement, or if any
representation or warranty of CGI shall have become untrue, incomplete or
incorrect, in either case such that the conditions set forth in Section
8.02 would not be
37
<PAGE>
satisfied (a "Terminating CGI Breach"); provided, however, that, if such
Terminating CGI Breach is curable by CGI through the exercise of its
reasonable efforts within 60 days and for so long as CGI continues to
exercise such reasonable efforts, STC may not terminate this Agreement
under this Section 9.01(h); and provided further that the preceding proviso
shall not in any event be deemed to extend any date set forth in paragraph
(b) of this Section 9.01;
(i) by STC, if (A) the board of directors of STC shall have resolved to
accept, accepted or recommended to the shareholders of STC, a Superior
Proposal, and (B) in the case of the termination of this Agreement under
this Section 9.01(i) by STC, STC shall have paid to CGI all amounts owing
by STC to CGI under Section 9.05(b); and
(j) by CGI, if (A) the board of directors of CGI shall have resolved to
accept, accepted or recommended to the shareholders of CGI, a Superior
Proposal, and (B) in the case of the termination of this Agreement under
this Section 9.01(j) by CGI, CGI shall have paid to STC all amounts owing
by CGI to STC under Section 9.05(c).
SECTION 9.02. Effect of Termination. Except as provided in Section 9.05, in
the event of termination of this Agreement pursuant to Section 9.01, this
Agreement shall forthwith become void, there shall be no liability under this
Agreement on the part of CGI or STC or any of their respective officers or
directors, and all rights and obligations of each party hereto shall cease,
subject to the remedies of the parties hereto set forth in Section 9.05(b),
(c), (d) and (e); provided, however, that nothing herein shall relieve any
party hereto from liability for the willful or intentional breach of any of
its representations and warranties or the willful or intentional breach of any
of its covenants or agreements set forth in this Agreement.
SECTION 9.03. Amendment. This Agreement may be amended by the parties hereto
by action taken by or on behalf of their respective boards of directors at any
time prior to the Effective Time; provided, however, that, after the approval
of this Agreement by the stockholders of STC or CGI, as the case may be, no
amendment may be made, except such amendments as have received the requisite
stockholder approval and such amendments as are permitted to be made without
stockholder approval under the General Corporation Law. This Agreement may not
be amended except by an instrument in writing signed by the parties hereto.
SECTION 9.04. Waiver. At any time prior to the Effective Time, any party
hereto may (a) extend the time for or waive compliance with the performance of
any obligation or other act of any other party hereto or (b) waive any
inaccuracy in the representations and warranties contained herein or in any
document delivered pursuant hereto. Any such extension or waiver shall be
valid if set forth in an instrument in writing signed by the party or parties
to be bound thereby.
SECTION 9.05. Expenses. (a) Except as set forth in this Section 9.05, all
Expenses incurred in connection with this Agreement, the STC Stock Option
Agreement, the CGI Stock Option Agreement and the Merger shall be paid by the
party incurring such Expenses, whether or not the Merger is consummated,
except that CGI and STC each shall pay one-half of all Expenses incurred
solely for printing, filing and mailing the Registration Statement and the
Joint Proxy Statement and all SEC and other regulatory filing fees incurred in
connection with the Registration Statement and the Joint Proxy Statement and
any fees required to be paid under the HSR Act.
(b) In the event that CGI shall terminate this Agreement pursuant to Section
9.01(d), (f)(i) or (g), or STC shall terminate this Agreement pursuant to
Section 9.01(f)(i) or (i), then STC shall pay to CGI an amount equal to
$3,000,000 plus all of CGI's Expenses.
(c) In the event that STC shall terminate this Agreement pursuant to Section
9.01(e), (f)(ii) or (h) or CGI shall terminate this Agreement pursuant to
Section 9.01(f)(ii) or (j), CGI shall pay to STC an amount equal to $3,000,000
plus all of STC's Expenses.
38
<PAGE>
(d) Any payment required to be made pursuant to Section 9.05(b) or (c) shall
be made to the party entitled to receive such payment not later than two
business days after delivery to the other party of notice of demand for
payment and shall be made by wire transfer of immediately available funds to
an account designated by the party entitled to receive payment in the notice
of demand for payment delivered pursuant to this Section 9.05(d); provided,
however, that, in the event both CGI and STC would otherwise be entitled to
payments under this Section 9.05 in connection with the termination of this
Agreement pursuant to both Sections 9.01(f)(i) and (f)(ii), neither party
shall be required to make any payment under this Section 9.05.
(e) In the event that CGI or STC, as the case may be, shall fail timely to
make any payment on Expense reimbursement required to be made pursuant to
Section 9.05(b) or (c), the amount of any such required payment on Expense
reimbursement shall be increased to include the costs and expenses actually
incurred or accrued by the other (including, without limitation, fees and
expenses of counsel) in connection with the collection under and enforcement
of this Section 9.05, together with interest on such unpaid Expense
reimbursement, commencing on the date that such Expense reimbursement became
due, at a rate equal to the rate of interest publicly announced by Citibank,
N.A., from time to time, in The City of New York, from time to time, as such
bank's base rate plus 3.00 percent per annum.
ARTICLE X
GENERAL PROVISIONS
SECTION 10.01. Non-Survival of Representations and Warranties. The
representations and warranties in this Agreement shall terminate at the
Effective Time or upon the termination of this Agreement pursuant to Section
9.01, as the case may be. Each party agrees that, except for the
representations and warranties contained in this Agreement and the CGI
Disclosure Schedule and the STC Disclosure Schedule, no party hereto has made
any other representations and warranties, and each party hereby disclaims any
other representations and warranties made by itself or any of its officers,
directors, employees, agents, financial and legal advisors or other
representatives, with respect to the execution and delivery of this Agreement
or the Merger contemplated herein, notwithstanding the delivery or disclosure
to any other party or any party's representatives of any documentation or
other information with respect to any one or more of the foregoing.
SECTION 10.02. Notices. All notices, requests, claims, demands and other
communications hereunder shall be in writing and shall be given (and shall be
deemed to have been duly given upon receipt) by delivery in person, by
telecopy or facsimile, by registered or certified mail (postage prepaid,
return receipt requested) or by a nationally recognized courier service to the
respective parties at their addresses set forth on the signature pages to this
Agreement (or at such other address for a party as shall be specified in a
notice given in accordance with this Section 10.02).
SECTION 10.03. Severability. If any term or other provision of this
Agreement is invalid, illegal or incapable of being enforced by any rule of
Law or public policy, all other conditions and provisions of this Agreement
shall nevertheless remain in full force and effect so long as the economic or
legal substance of the Merger is not affected in any manner materially adverse
to any party. Upon such determination that any term or other provision is
invalid, illegal or incapable of being enforced, the parties hereto shall
negotiate in good faith to modify this Agreement so as to effect the original
intent of the parties as closely as possible in a mutually acceptable manner
to the fullest extent permitted by applicable Law in order that the Merger may
be consummated as originally contemplated to the fullest extent possible.
SECTION 10.04. Assignment; Binding Effect; Benefit. Neither this Agreement
nor any of the rights, interests or obligations hereunder shall be assigned by
any of the parties hereto (whether by operation of Law or otherwise) without
the prior written consent of the other parties hereto. Subject to the
preceding sentence, this Agreement shall be binding upon and shall inure to
the benefit of the parties hereto and their respective successors and
permitted assigns. Notwithstanding anything contained in this Agreement to the
contrary, other than Section 7.06, nothing in this Agreement, expressed or
implied, is intended to confer on any person other than the parties hereto or
their respective successors and permitted assigns any rights or remedies under
or by reason of this Agreement.
39
<PAGE>
SECTION 10.05. Incorporation of Exhibits. The CGI Disclosure Schedule, the
STC Disclosure Schedule and all Exhibits attached hereto and referred to
herein are hereby incorporated herein and made a part of this Agreement for
all purposes as if fully set forth herein.
SECTION 10.06. Specific Performance. The parties hereto agree that
irreparable damage would occur in the event any provision of this Agreement
were not performed in accordance with the terms hereof and that the parties
shall be entitled to specific performance of the terms hereof, in addition to
any other remedy at law or in equity.
SECTION 10.07. Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY, AND
CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE,
WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAWS.
SECTION 10.08. Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY
WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED ON
CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR
ANY TRANSACTION OR AGREEMENT CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY
HERETO IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.
SECTION 10.09. Headings. The descriptive headings contained in this
Agreement are included for convenience of reference only and shall not affect
in any way the meaning or interpretation of this Agreement.
SECTION 10.10. Counterparts. This Agreement may be executed and delivered
(including by facsimile transmission) in one or more counterparts, and by the
different parties hereto in separate counterparts, each of which when executed
and delivered shall be deemed to be an original but all of which taken
together shall constitute one and the same agreement.
SECTION 10.11. Entire Agreement. This Agreement (including the Exhibits, the
CGI Disclosure Schedule and the STC Disclosure Schedule), the STC Stock Option
Agreement and the CGI Stock Option Agreement constitute the entire agreement
among the parties with respect to the subject matter hereof and supersede all
prior agreements and understandings among the parties with respect thereto. No
addition to or modification of any provision of this Agreement shall be
binding upon any party hereto unless made in writing and signed by all parties
hereto.
40
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed as of the date first written above by their respective officers
thereunto duly authorized.
CELL GENESYS, INC.
By: /s/ Stephen A. Sherwin
___________________________________
Stephen A. Sherwin, M.D.
Chairman of the Board, President
and Chief Executive Officer
342 Lakeside Drive
Foster City, California 94404
Telephone: (415) 358-9600
Telecopy: (415) 358-0230
Attention: Kathleen Sereda Glaub
with a copy to:
Shearman & Sterling
555 California Street
San Francisco, California 94104-1522
Telephone: (415) 616-1100
Telecopy: (415) 616-1199
Attention: Michael J. Kennedy
S MERGER CORP.
By: /s/ Kathleen Sereda Glaub
___________________________________
Kathleen Sereda Glaub
Chairman of the Board and
President
c/o Cell Genesys, Inc.
342 Lakeside Drive
Foster City, California 94404
Telephone: (415) 358-9600
Telecopy: (415) 358-0230
Attention: Kathleen Sereda Glaub
41
<PAGE>
EXHIBIT 99.1
Abgenix and Japan Tobacco Cross License Human Monoclonal Antibody Technology
With GenPharm
Agreement Includes Settlement of Litigation
FOSTER CITY, Calif., March 27 /PRNewswire/ -- Cell Genesys, Inc.
(Nasdaq: CEGE) today announced that the company, its subsidiary Abgenix, Inc.
and Japan Tobacco Inc. have entered into a comprehensive patent cross-license
and settlement agreement with GenPharm International for human monoclonal
antibody technology. The technology involves genetically modified strains of
mice capable of producing fully human monoclonal antibodies for disease
therapy. In addition, as part of the cross-license agreement, Cell Genesys
was granted a worldwide non-exclusive license in the field of gene therapy to
certain technology of GenPharm. The agreement also resolves all related
litigation and claims between the parties.
The agreement includes a worldwide royalty-free cross-license to all
issued and related patent applications pertaining to the generation of fully
human monoclonal antibodies in genetically modified strains of mice. The
issued patents include claims covering the introduction of human antibody
genes into mice as well as the inactivation of mouse antibody genes and
include a European patent granted to Cell Genesys and several U.S. patents
issued to GenPharm most recently during the first quarter of this year. The
parties believe that the intellectual property contributions to the
cross-license agreement from both sides will enhance their ability to freely
commercialize their human monoclonal antibody technologies.
In consideration of the cross-license and settlement agreement, Cell
Genesys agreed to issue a note due September 30, 1998 for $15,000,000, which
bears interest at 7% per year and is convertible at the option of GenPharm
into 1,666,666 shares of Cell Genesys common stock at $9.00 per share. The
conversion price is subject to reset in twelve months. In addition, Japan
Tobacco agreed to make a cash payment to GenPharm. The agreement also calls
for two potential milestone payments of $7,500,000 each to GenPharm based on
the future issuance of certain patents relating to human monoclonal antibody
technology in Europe, Japan and/or the United States. These payments will be
made by Xenotech, L.P., which is an equal joint venture of Abgenix and Japan
Tobacco.
Abgenix, a subsidiary of Cell Genesys, is focused on the development and
commercialization of antibodies to treat a wide range of serious diseases,
including transplantation-associated conditions, inflammation, autoimmune
disorders and cancer. The company has developed novel strains of transgenic
mice that are capable of generating fully human antibodies.
Cell Genesys is focused on the development and commercialization of ex
vivo and in vivo gene therapies to treat major, life-threatening diseases and
disorders. The company's AIDS gene therapy is in Phase II human clinical
testing and is being developed through a worldwide collaboration with Hoechst
Marion Roussel, Inc. Cancer gene therapy, for which Cell Genesys currently
has worldwide rights, is in preclinical testing for colon, ovarian and other
specific types of cancer. These and other gene therapy programs utilize
proprietary, engineered genes and gene delivery systems. The company's assets
outside of gene therapy include its Abgenix, Inc. subsidiary, as well as the
company's licensing program in gene activation technology.
GenPharm International, Inc. is a world leader in the development of human
<PAGE>
monoclonal antibodies from transgenic mice for therapeutic and diagnostic
uses.
NOTE: Statements made in this press release other than statements of
historical fact, including statements about the company's and its subsidiary's
clinical trials, product pipelines, corporate partnerships, licenses and
intellectual property, are forward looking statements and are subject to a
number of uncertainties that could cause actual results to differ materially
from the statements made, including risks associated with the success of
research and product development programs, patents, proprietary technology and
corporate partnerships. Please see the company's Form 10-K dated March
28, 1996, including the portions of the Annual Report to Stockholders
incorporated therein by reference as well as the company's reports on Forms
10-Q and 8-K and other documents filed from time to time with the Securities
and Exchange Commission, for information about risks associated with product
development programs, intellectual property and other risks which may affect
the company. The company does not undertake any obligation to update
forward-looking statements.
SOURCE Cell Genesys Inc.
CONTACT: R. Scott Greer, President and Chief Executive Officer of Abgenix, Inc.,
510-608-6565; or Kathleen Sereda Glaub, Senior Vice President and Chief
Financial Officer of Cell Genesys, Inc., 415-358-9600, ext. 242
